##analysisDate=2017-05-10-14-07-34000
##analyzedBy=RingStudy Site F
##exportDate=2017-11-08-10-50-06000
##analysisName=Site F-081-Sample 9_F
##workflowName=Oncomine Comprehensive v3 - w2.1 - DNA and Fusions - Single Sample
##sampleNames=Site F-081-Sample 9-F_v1:Site F-081-Sample 9-F_RNA_v1
##reference=hg19
##variantGroup=DEFAULT
##filterChain=Site D_NoRef
##searchText=
##chromosome=All
##totalVariantCount=2467
##filterInCount=126
##filteredOutCount=2341
##hiddenVariantCount=0
Locus	Genotype	Ref	Type	No Call Reason	Genes	Location	Length	Oncomine Variant Class	Oncomine Gene Class	Copy Number	CytoBand	Info	Variant ID	Variant Name	% Frequency	Amino Acid Change	Read Counts	Coverage	Allele Ratio	CNV Confidence	Detection	3'/5' Imbalance	COSMIC/NCBI	Read Counts Per Million	Strand	Exon	Transcript	Coding	Variant Effect	PhyloP	SIFT	Grantham	PolyPhen	PFAM	dbSNP	DGV	MAF	EMAF	AMAF	GMAF	UCSC Common SNPs	Gene Ontology	DrugBank	ClinVar	p-value	Phred QUAL Score	Allele Coverage	CNV Precision	Ref+/Ref-/Var+/Var-	Homopolymer Length	Tiles
chr1:11184624	A/C	A	SNV		MTOR	exonic	1								23.91	p.Val2198Gly		1999	A=0.7609, C=0.2391		Present				-	47	NM_004958.3	c.6593T>G	missense	2.23	0.01	109.0	1.0	FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase								ATP binding,Golgi apparatus,Golgi membrane,PML body,RNA polymerase III type 1 promoter DNA binding,RNA polymerase III type 2 promoter DNA binding,RNA polymerase III type 3 promoter DNA binding,T cell costimulation,TFIIIC-class transcription factor binding,TOR signaling cascade,TORC1 complex,TORC2 complex,cell growth,cellular response to hypoxia,cellular response to nutrient levels,cytoplasm,cytosol,dendrite,endomembrane system,endoplasmic reticulum,endoplasmic reticulum membrane,fibroblast growth factor receptor signaling pathway,germ cell development,growth,insulin receptor signaling pathway,kinase activity,lysosome,mTOR-FKBP12-rapamycin complex,membrane,mitochondrial outer membrane,mitochondrion,negative regulation of NFAT protein import into nucleus,negative regulation of autophagy,negative regulation of cell size,negative regulation of macroautophagy,nerve growth factor receptor signaling pathway,neuronal cell body,nucleotide binding,nucleus,peptidyl-serine phosphorylation,peptidyl-threonine phosphorylation,phosphatidylinositol 3-kinase complex,phosphatidylinositol-mediated signaling,phosphoprotein binding,phosphorylation,phosphotransferase activity, alcohol group as acceptor,positive regulation of actin filament polymerization,positive regulation of endothelial cell proliferation,positive regulation of lamellipodium assembly,positive regulation of lipid biosynthetic process,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of protein kinase B signaling cascade,positive regulation of protein phosphorylation,positive regulation of stress fiber assembly,positive regulation of transcription from RNA polymerase III promoter,positive regulation of translation,protein autophosphorylation,protein binding,protein catabolic process,protein domain specific binding,protein phosphorylation,protein serine/threonine kinase activity,regulation of Rac GTPase activity,regulation of actin cytoskeleton organization,regulation of carbohydrate metabolic process,regulation of carbohydrate utilization,regulation of fatty acid beta-oxidation,regulation of glycogen biosynthetic process,regulation of protein kinase activity,regulation of response to food,response to amino acid stimulus,response to insulin stimulus,response to nutrient,ribosome binding,ruffle organization,signal transduction,soluble fraction	Everolimus,Pimecrolimus,Sirolimus,Temsirolimus		0.00001	2742.17	A=1521, C=478		A=826/695, C=247/231	1	
chr1:40363054	C/C	G	SNV		MYCL	exonic	1								100.00	p.Thr392Ser		314	G=0.0, C=1.0		Present				-	3	NM_001033082.2	c.1175C>G	missense	1.32	1.0	58.0	0.0	Helix-loop-helix DNA-binding domain,Myc amino-terminal region	rs3134614		0.055 (ref)	0.1328	0.0252	0.0963	YES	DNA binding,nucleus,regulation of transcription, DNA-dependent,sequence-specific DNA binding transcription factor activity			0.00001	4753.12	G=0, C=314		G=0/0, C=144/170	1	
chr1:65310489	T/C	T	SNV		JAK1	exonic	1								39.81	p.(=)		1957	T=0.6019, C=0.3981		Present				-	16	NM_002227.2	c.2199A>G	synonymous	-4.13				Protein kinase domain,Protein tyrosine kinase	rs2230588		0.352 (ref)	0.2323	0.418	0.3492	YES	ATP binding,cytokine-mediated signaling pathway,cytoplasm,cytoskeleton,cytosol,endomembrane system,growth hormone receptor binding,interferon-gamma-mediated signaling pathway,intracellular protein kinase cascade,intracellular signal transduction,membrane,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,protein binding,protein phosphorylation,protein tyrosine kinase activity,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,response to antibiotic,type I interferon-mediated signaling pathway	2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZH-IMIDAZ4,5-FISOQUINOLIN-7-ONE,3-{(3R,4R)-4-methyl-3-methyl(7H-pyrrolo2,3-dpyrimidin-4-yl)aminopiperidin-1-yl}-3-oxopropanenitrile		0.00001	6328.74	T=1178, C=779		T=584/594, C=356/423	1	
chr1:156849949		G	GENE_EXPRESSION		NTRK1								NTRK1.E16E17				715				Present			3.8613e-10																						0.0					
chr1:162729613	C/T	C	SNV		DDR2	exonic	1								66.64	p.(=)		1283	C=0.3336, T=0.6664		Present				+	8	NM_006182.2	c.699C>T	synonymous	-1.76				F5/8 type C domain,Protein kinase domain,Protein tyrosine kinase	rs56351141		0.007 (ref)	0.0138	0.002	0.0098		ATP binding,cell adhesion,chondrocyte proliferation,collagen binding,integral to plasma membrane,nucleotide binding,ossification,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of cell cycle arrest,positive regulation of fibroblast migration,positive regulation of fibroblast proliferation,positive regulation of osteoblast differentiation,positive regulation of protein kinase activity,positive regulation of sequence-specific DNA binding transcription factor activity,protein autophosphorylation,receptor activity,regulation of bone mineralization,regulation of extracellular matrix disassembly,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.00001	9518.16	C=428, T=855		C=219/209, T=464/391	2	
chr1:204485637		G	GENE_EXPRESSION		MDM4								MDM4.E1E2				2136				Present			1.1535e-09																						0.0					
chr1:204494724		G	GENE_EXPRESSION		MDM4								MDM4.E3E4				128352				Present			6.9315e-08																						0.0					
chr1:204507436		G	GENE_EXPRESSION		MDM4								MDM4-MDM4.M7M10				3346				Present			1.8070e-09																						0.0					
chr2:29443583		G	GENE_EXPRESSION		ALK								ALK.3p.E22E23				992				Present			5.3572e-10																						0.0					
chr2:29455223		C	GENE_EXPRESSION		ALK								ALK.5p.E14E15				400				Present			2.1602e-10																						0.0					
chr2:48010488	G/A	G	SNV		MSH6	exonic	1								42.41	p.Gly39Glu		823	G=0.5759, A=0.4241		Present				+	1	NM_000179.2	c.116G>A	missense	0.84	0.06	98.0	0.0	MutS domain I,MutS domain II,MutS domain III,MutS domain V,MutS family domain IV,PWWP domain	rs1042821		0.193 (ref)	0.1724	0.194	0.1797	YES	ADP binding,ATP binding,ATP catabolic process,ATPase activity,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent ATPase activity,MutLalpha complex binding,MutSalpha complex,chromatin binding,damaged DNA binding,determination of adult lifespan,double-stranded DNA binding,four-way junction DNA binding,guanine/thymine mispair binding,induction of apoptosis by intracellular signals,isotype switching,magnesium ion binding,maintenance of DNA repeat elements,meiotic mismatch repair,mismatch repair,mismatched DNA binding,negative regulation of DNA recombination,nuclear chromatin,nuclear chromosome,nucleotide binding,nucleus,oxidized purine DNA binding,positive regulation of helicase activity,protein binding,protein homodimerization activity,reciprocal meiotic recombination,response to UV,single guanine insertion binding,single thymine insertion binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments		non-pathogenic,probable-non-pathogenic	0.00001	2953.35	G=474, A=349		G=269/205, A=181/168	4	
chr2:48032756	G/A	G	SNV		MSH6	splicesite_5	1								12.00			25	G=0.88, A=0.12		Present				+	7	NM_000179.2			2.62				MutS domain I,MutS domain II,MutS domain III,MutS domain V,MutS family domain IV,PWWP domain								ADP binding,ATP binding,ATP catabolic process,ATPase activity,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent ATPase activity,MutLalpha complex binding,MutSalpha complex,chromatin binding,damaged DNA binding,determination of adult lifespan,double-stranded DNA binding,four-way junction DNA binding,guanine/thymine mispair binding,induction of apoptosis by intracellular signals,isotype switching,magnesium ion binding,maintenance of DNA repeat elements,meiotic mismatch repair,mismatch repair,mismatched DNA binding,negative regulation of DNA recombination,nuclear chromatin,nuclear chromosome,nucleotide binding,nucleus,oxidized purine DNA binding,positive regulation of helicase activity,protein binding,protein homodimerization activity,reciprocal meiotic recombination,response to UV,single guanine insertion binding,single thymine insertion binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments			0.04239	13.7278	G=22, A=3		G=9/13, A=1/2	2	
chr3:10094159	A/G	A	SNV		FANCD2	exonic	1								50.15	p.Asn545Ser		1998	A=0.4985, G=0.5015		Present				+	18	NM_033084.3	c.1634A>G	missense	0.32	0.78	46.0	0.06		rs145522204		0.005 (ref)	0.0081	5.0E-4	0.0055		DNA repair,cell cycle,condensed chromosome,gamete generation,nucleoplasm,nucleus,protein binding,response to gamma radiation,synapsis			0.00001	9435.59	A=996, G=1002		A=608/388, G=588/414	2	
chr3:12393125	C/G	C	SNV		PPARG	exonic	1								47.97	p.Pro12Ala		1747	C=0.5203, G=0.4797		Present				+	1	NM_015869.4	c.34C>G	missense	0.86	0.01	27.0	0.0	Ligand-binding domain of nuclear hormone receptor,Zinc finger	rs1801282		0.066 (ref)	0.1236	0.0261	0.0906	YES	DNA binding,activating transcription factor binding,activation of caspase activity,arachidonic acid binding,cell fate commitment,cell maturation,cellular response to insulin stimulus,cytoplasm,cytosol,drug binding,enzyme binding,epithelial cell differentiation,gene expression,glucose homeostasis,heart development,induction of apoptosis,innate immune response,intracellular receptor mediated signaling pathway,ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity,lipid homeostasis,lipid metabolic process,lipoprotein transport,long-chain fatty acid transport,low-density lipoprotein particle receptor biosynthetic process,metal ion binding,monocyte differentiation,negative regulation of acute inflammatory response,negative regulation of cell growth,negative regulation of cell proliferation,negative regulation of cholesterol storage,negative regulation of interferon-gamma-mediated signaling pathway,negative regulation of macrophage derived foam cell differentiation,negative regulation of receptor biosynthetic process,negative regulation of sequestering of triglyceride,negative regulation of telomerase activity,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,organ regeneration,placenta development,positive regulation of fat cell differentiation,positive regulation of fatty acid oxidation,positive regulation of oligodendrocyte differentiation,positive regulation of sequence-specific DNA binding transcription factor activity,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,prostaglandin receptor activity,protein binding,receptor activity,regulation of blood pressure,regulation of cholesterol transporter activity,regulation of lipid metabolic process,response to caffeine,response to cold,response to drug,response to estrogen stimulus,response to lipid,response to low-density lipoprotein particle stimulus,response to nutrient,response to organic cyclic compound,response to vitamin A,retinoid X receptor binding,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,signal transduction,steroid hormone receptor activity,transcription regulatory region DNA binding,white fat cell differentiation,zinc ion binding	(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid,(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,(2S)-2-ETHOXY-3-{4-2-(10H-PHENOXAZIN-10-YL)ETHOXYPHENYL}PROPANOIC ACID,(2S)-2-methoxy-3-{4-2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy-1-benzothiophen-7-yl}propanoic acid,(2S)-3-(1-{2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YLMETHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID,(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid,(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid,(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid,(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid,(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid,(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid,(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid,(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,2-(2,4-DICHLOROBENZOYL)AMINO-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID,2-chloro-5-nitro-N-phenylbenzamide,2-{5-3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXYINDOL-1-YL}ETHANOIC ACID,2-{5-3-(7-PROPYL-3-TRIFLUOROMETHYLBENZODISOXAZOL-6-YLOXY)PROPOXYINDOL-1-YL}ETHANOIC ACID,3-(5-methoxy-1H-indol-3-yl)propanoic acid,3-5-(2-nitropent-1-en-1-yl)furan-2-ylbenzoic acid,3-FLUORO-N-1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YLBENZENESULFONAMIDE,3-{5-methoxy-1-(4-methoxyphenyl)sulfonyl-1H-indol-3-yl}propanoic acid,Balsalazide,Bezafibrate,Glipizide,Icosapent,Indomethacin,Mesalazine,Mitiglinide,Nateglinide,Pioglitazone,Repaglinide,Rosiglitazone,Sulfasalazine,Telmisartan,Troglitazone,difluoro(5-{2-(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene-2H-pyrrol-5-yl-kappaN}pentanoato)boron	untested	0.00001	7655.75	C=909, G=838		C=464/445, G=422/416	3	
chr3:47103692	G/A	G	SNV		SETD2	exonic	1								34.63	p.Ser2085Phe		1998	G=0.6537, A=0.3463		Present				-	14	NM_014159.6	c.6254C>T	missense	2.53	0.01	155.0	0.07	SET domain,WW domain								DNA binding,chromatin modification,chromosome,histone H3-K36 methylation,histone-lysine N-methyltransferase activity,methyltransferase activity,nucleus,oxidoreductase activity,peptidyl-lysine trimethylation,protein binding,regulation of transcription, DNA-dependent,transferase activity,transition metal ion binding			0.00001	5119.92	G=1306, A=692		G=469/837, A=219/473	1	
chr3:47125385	A/A	G	SNV		SETD2	exonic	1								100.00	p.Pro1962Leu		1998	G=0.0, A=1.0		Present				-	12	NM_014159.6	c.5885C>T	missense	0.33	0.06	98.0	0.0	SET domain,WW domain	rs4082155		0.496 (ref)	0.4338	0.2862	0.4713	YES	DNA binding,chromatin modification,chromosome,histone H3-K36 methylation,histone-lysine N-methyltransferase activity,methyltransferase activity,nucleus,oxidoreductase activity,peptidyl-lysine trimethylation,protein binding,regulation of transcription, DNA-dependent,transferase activity,transition metal ion binding			0.00001	30418.1	G=0, A=1998		G=0/0, A=1074/924	3	
chr3:47162661	G/G	A	SNV		SETD2	exonic	1								100.00	p.(=)		1840	A=0.0, G=1.0		Present				-	3	NM_014159.6	c.3465T>C	synonymous	-0.59				SET domain,WW domain	rs6767907		0.316 (ref)	0.4088	0.2506	0.3552	YES	DNA binding,chromatin modification,chromosome,histone H3-K36 methylation,histone-lysine N-methyltransferase activity,methyltransferase activity,nucleus,oxidoreductase activity,peptidyl-lysine trimethylation,protein binding,regulation of transcription, DNA-dependent,transferase activity,transition metal ion binding			0.00001	27952.6	A=0, G=1840		A=0/0, G=898/942	1	
chr3:142178144	T/T	C	SNV		ATR	exonic	1								100.00	p.Arg2425Gln		1998	C=0.0, T=1.0		Present				-	43	NM_001184.3	c.7274G>A	missense	-2.53	0.5	43.0	0.0	FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain	rs2229032		0.12 (ref)	0.1578	0.0881	0.1342	YES	ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus			0.00001	30416.9	C=0, T=1998		C=0/0, T=1053/945	1	
chr3:142188337	C/C	A	SNV		ATR	exonic	1								100.00	p.Tyr2132Asp		1996	A=0.0, C=1.0		Present				-	38	NM_001184.3	c.6394T>G	missense	0.09	0.69	160.0	0.001	FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain	rs28910273		0.002 (ref)	0.0069	0.002	0.0052		ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus			0.00001	30330.1	A=0, C=1996		A=0/0, C=926/1070	1	
chr3:142277575	T/T	A	SNV		ATR	exonic	1								100.00	p.(=)		208	A=0.0, T=1.0		Present				-	8	NM_001184.3	c.1776T>A	synonymous	-0.09				FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain	rs2227930		0.382 (ref)	0.405	0.2043	0.337	YES	ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus			0.00001	3082.5	A=0, T=208		A=0/0, T=105/103	1	
chr3:142281612	G/G	A	SNV		ATR	exonic	1								99.48	p.Met211Thr		192	A=0.0052, G=0.9948		Present				-	4	NM_001184.3	c.632T>C	missense	0.55	1.0	81.0	0.0	FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase,UME (NUC010) domain	rs2227928		0.383 (ref)	0.4045	0.2072	0.3377	YES	ATP binding,DNA binding,DNA damage checkpoint,DNA repair,DNA replication,MutLalpha complex binding,MutSalpha complex binding,PML body,XY body,cell cycle,cell cycle checkpoint,cellular response to UV,cellular response to gamma radiation,multicellular organismal development,negative regulation of DNA replication,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,protein autophosphorylation,protein binding,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of protein binding,replicative senescence,response to DNA damage stimulus			0.00001	2869.03	A=1, G=191		A=1/0, G=85/106	1	
chr4:1807894	A/A	G	SNV		FGFR3	exonic	1								100.00	p.(=)		1997	G=0.0, A=1.0		Present				+	14	NM_000142.4	c.1953G>A	synonymous	0.05				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs7688609		0.042 (ref)	8.0E-4	0.131	0.0449	YES	ATP binding,JAK-STAT cascade,MAPKKK cascade,bone maturation,bone morphogenesis,chondrocyte differentiation,chondrocyte proliferation,cytoplasmic membrane-bounded vesicle,endochondral bone growth,endochondral ossification,endoplasmic reticulum,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,focal adhesion,insulin receptor signaling pathway,integral to plasma membrane,negative regulation of developmental growth,nucleotide binding,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phospholipase activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,protein autophosphorylation,protein binding,protein tyrosine kinase activity,receptor activity,regulation of apoptotic process,skeletal system development	Palifermin,Pazopanib		0.00001	30373.5	G=0, A=1997		G=0/0, A=977/1020	1	
chr4:55141051	GCCCGGATGGACATGA/GCCCGGATGGACATGA	GCCCAGATGGACATGA	SNV		PDGFRA	exonic	1					HS	COSM12418		G=0.00, GCCCGGATGGACATGA=100.00	p.(=)		1145	GCCCAGATGGACATGA=0.0, G=0.0, GCCCGGATGGACATGA=1.0		Present				+	12	NM_006206.4	c.1701A>G	synonymous	2.79,2.74,2.74,2.74,-5.31,2.74,2.21,0.99,2.74,2.74,0.41,2.64,2.31,-0.28,1.57,2.31				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs121913270,rs121913271,rs1873778,rs201503614		0.037				YES	ATP binding,Leydig cell differentiation,adrenal gland development,cardiac myofibril assembly,cell activation,cell chemotaxis,cellular response to amino acid stimulus,cytoplasm,elevation of cytosolic calcium ion concentration,embryonic cranial skeleton morphogenesis,embryonic digestive tract morphogenesis,embryonic skeletal system morphogenesis,estrogen metabolic process,extracellular matrix organization,face morphogenesis,female gonad development,gliogenesis,growth factor binding,in utero embryonic development,inner ear development,integral to plasma membrane,intrinsic to plasma membrane,lung development,luteinization,male genitalia development,metanephric glomerular capillary formation,multicellular organismal development,negative regulation of platelet activation,nucleotide binding,nucleus,odontogenesis of dentin-containing tooth,palate development,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,phosphatidylinositol-mediated signaling,plasma membrane,platelet aggregation,platelet-derived growth factor alpha-receptor activity,platelet-derived growth factor binding,platelet-derived growth factor receptor binding,platelet-derived growth factor receptor signaling pathway,platelet-derived growth factor receptor-alpha signaling pathway,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,protein autophosphorylation,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,regulation of actin cytoskeleton reorganization,regulation of chemotaxis,regulation of mesenchymal stem cell differentiation,response to cytokine stimulus,response to estradiol stimulus,response to hormone stimulus,response to hyperoxia,response to inorganic substance,retina vasculature development in camera-type eye,signal transduction involved in regulation of gene expression,transmembrane receptor protein tyrosine kinase activity,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity,wound healing	Becaplermin,Imatinib,Pazopanib,Sunitinib		0.00001	16632.5	GCCCAGATGGACATGA=0, G=0, GCCCGGATGGACATGA=1145		GCCCAGATGGACATGA=0/0, G=0/0, GCCCGGATGGACATGA=561/584	3,1	
chr5:1294086	C/T	C	SNV		TERT	exonic	1								52.50	p.(=)		1998	C=0.475, T=0.525		Present				-	2	NM_198253.2	c.915G>A	synonymous	-1.35					rs2736098		0.213 (ref)	0.2597	0.1051	0.2075	YES	DNA binding,DNA strand elongation,PML body,anti-apoptosis,chromosome,chromosome, telomeric region,cytoplasm,metal ion binding,nuclear telomere cap complex,nucleolus,nucleoplasm,nucleotidyltransferase activity,nucleus,protein binding,protein homodimerization activity,replicative senescence,telomerase activity,telomerase holoenzyme complex,telomere formation via telomerase,telomere maintenance,telomere maintenance via telomerase,telomeric DNA binding,telomeric RNA binding,telomeric template RNA reverse transcriptase activity,transferase activity		non-pathogenic	0.00001	10158.9	C=949, T=1049		C=448/501, T=460/589	3	
chr5:38942449	G/A	G	SNV		RICTOR	exonic	1								43.64	p.Thr1695Ile		346	G=0.5636, A=0.4364		Present				-	38	NM_152756.4	c.5084C>T	missense	-0.73	0.49	89.0	0.0		rs61748204		0.018 (ref)	0.0214	0.0379	0.027	YES	T cell costimulation,TORC2 complex,actin cytoskeleton reorganization,cytosol,embryo development,fibroblast growth factor receptor signaling pathway,nerve growth factor receptor signaling pathway,phosphatidylinositol-mediated signaling,positive regulation of TOR signaling cascade,positive regulation of actin filament polymerization,positive regulation of peptidyl-tyrosine phosphorylation,protein binding,regulation of Rac GTPase activity,regulation of actin cytoskeleton organization,regulation of protein kinase B signaling cascade,ribosome binding			0.00001	1301.31	G=195, A=151		G=91/104, A=87/64	1	
chr5:67588148	G/A	G	SNV		PIK3R1	exonic	1								78.17	p.Met326Ile		1365	G=0.2183, A=0.7817		Present				+	8	NM_181523.2	c.978G>A	missense	1.5	0.42	10.0	0.0	RhoGAP domain,SH2 domain,SH3 domain	rs3730089		0.218 (ref)	0.1645	0.3822	0.2383	YES	1-phosphatidylinositol binding,1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex,ErbB-3 class receptor binding,T cell costimulation,T cell receptor signaling pathway,blood coagulation,cytosol,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,growth hormone receptor signaling pathway,insulin binding,insulin receptor binding,insulin receptor signaling pathway,insulin receptor substrate binding,insulin-like growth factor receptor binding,insulin-like growth factor receptor signaling pathway,interspecies interaction between organisms,intracellular,leukocyte migration,nerve growth factor receptor signaling pathway,neurotrophin TRKA receptor binding,phosphatidylinositol 3-kinase cascade,phosphatidylinositol 3-kinase regulator activity,phosphatidylinositol phosphorylation,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,phosphatidylinositol-mediated signaling,platelet activation,positive regulation of establishment of protein localization in plasma membrane,positive regulation of glucose import,protein binding,protein phosphatase binding,signal transduction	(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-(METHYLOXY)METHYL-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO4,3,2-DEINDENO4,5-H2BENZOPYRAN-11-YL ACETATE,Isoproterenol		0.00001	13155.7	G=298, A=1067		G=142/156, A=484/583	1	
chr5:67591135	G/A	G	SNV		PIK3R1	exonic	1								73.36	p.(=)		259	G=0.2664, A=0.7336		Present				+	13	NM_181523.2	c.1728G>A	synonymous	-5.12				RhoGAP domain,SH2 domain,SH3 domain	rs149090706			6.0E-4	2.0E-4	5.0E-4		1-phosphatidylinositol binding,1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex,ErbB-3 class receptor binding,T cell costimulation,T cell receptor signaling pathway,blood coagulation,cytosol,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,growth hormone receptor signaling pathway,insulin binding,insulin receptor binding,insulin receptor signaling pathway,insulin receptor substrate binding,insulin-like growth factor receptor binding,insulin-like growth factor receptor signaling pathway,interspecies interaction between organisms,intracellular,leukocyte migration,nerve growth factor receptor signaling pathway,neurotrophin TRKA receptor binding,phosphatidylinositol 3-kinase cascade,phosphatidylinositol 3-kinase regulator activity,phosphatidylinositol phosphorylation,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,phosphatidylinositol-mediated signaling,platelet activation,positive regulation of establishment of protein localization in plasma membrane,positive regulation of glucose import,protein binding,protein phosphatase binding,signal transduction	(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-(METHYLOXY)METHYL-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO4,3,2-DEINDENO4,5-H2BENZOPYRAN-11-YL ACETATE,Isoproterenol		0.00001	2226.8	G=69, A=190		G=38/31, A=97/93	1	
chr6:41903782	A/C	A	SNV		CCND3	exonic	1								49.22	p.Ser259Ala		1993	A=0.5078, C=0.4922		Present				-	5	NM_001760.4	c.775T>G	missense	-0.25	0.59	99.0	0.0	Cyclin	rs1051130		0.415 (ref)	0.4535	0.2238	0.3757	YES	T cell proliferation,cell division,cyclin-dependent protein kinase activity,cyclin-dependent protein kinase holoenzyme complex,cytoplasm,membrane,nucleus,positive regulation of cyclin-dependent protein kinase activity,positive regulation of protein phosphorylation,protein binding,protein kinase binding,regulation of cell cycle,signal transduction			0.00001	9122.62	A=1012, C=981		A=464/548, C=451/530	1	
chr6:152129077	T/C	T	SNV		ESR1	exonic	1								50.28	p.(=)		1060	T=0.4972, C=0.5028		Present				+	2	NM_001122740.1	c.30T>C	synonymous	-1.28				Ligand-binding domain of nuclear hormone receptor,Oestrogen receptor,Zinc finger	rs2077647		0.432 (ref)	0.4769	0.4828	0.4789	YES	Sertoli cell proliferation,T-tubule,androgen metabolic process,antral ovarian follicle growth,beta-catenin binding,cellular response to estrogen stimulus,chromatin binding,chromatin remodeling complex,cytoplasm,enzyme binding,epithelial cell development,epithelial cell proliferation involved in mammary gland duct elongation,estrogen receptor activity,estrogen response element binding,gene expression,hormone binding,intracellular estrogen receptor signaling pathway,mammary gland alveolus development,mammary gland branching involved in pregnancy,membrane,metal ion binding,mitochondrial part,neuron projection,neuroprotection,nitric-oxide synthase regulator activity,nucleoplasm,nucleus,osteoblast development,perikaryon,perinuclear region of cytoplasm,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of fibroblast proliferation,positive regulation of retinoic acid receptor signaling pathway,positive regulation of survival gene product expression,positive regulation of transcription from RNA polymerase II promoter,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,protein binding,protein complex binding,receptor activity,regulation of apoptotic process,regulation of branching involved in prostate gland morphogenesis,regulation of transcription, DNA-dependent,response to estradiol stimulus,response to estrogen stimulus,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,signal transduction,steroid binding,steroid hormone mediated signaling pathway,steroid hormone receptor activity,terminal button,transcription factor binding,transcription, DNA-dependent,type 1 metabotropic glutamate receptor binding,uterus development,vagina development,zinc ion binding	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-4-(2-PYRROLIDIN-1-YLETHOXY)PHENYLCHROMAN-6-OL,(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-9-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(9ALPHA,13BETA,17BETA)-2-(1Z)-BUT-1-EN-1-YLESTRA-1,3,5(10)-TRIENE-3,17-DIOL,(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL,1-4-(Octahydro-Pyrido1,2-aPyrazin-2-Yl)-Phenyl-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,2-AMINO-1-METHYL-6-PHENYLIMIDAZO4,5-BPYRIDINE,2-Phenyl-1-4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,4-(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(2-amino-1-methyl-1H-imidazo4,5-bpyridin-6-yl)phenol,4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL,4-1-allyl-7-(trifluoromethyl)-1H-indazol-3-ylbenzene-1,3-diol,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YLACETONITRILE,Allylestrenol,Chlorotrianisene,Clomifene,Compound 18,Compound 19,Compound 4-D,Conjugated Estrogens,DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO2.2.1HEPT-5-ENE-2,3-DICARBOXYLATE,Danazol,Desogestrel,Dienestrol,Diethylstilbestrol,Estradiol,Estramustine,Estriol,Estrone,Estropipate,Ethinyl Estradiol,Ethynodiol Diacetate,Etonogestrel,Fluoxymesterone,Fulvestrant,Genistein,Levonorgestrel,Medroxyprogesterone,Melatonin,Mestranol,N-(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,Naloxone,Norgestimate,Progesterone,Quinestrol,RALOXIFENE CORE,Raloxifene,Tamoxifen,Toremifene,Trilostane,dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo2.2.1hepta-2,5-diene-2,3-dicarboxylate		0.00001	5007.41	T=527, C=533		T=305/222, C=301/232	1	
chr6:152201875	C/C	T	SNV		ESR1	exonic	1								100.00	p.(=)		1997	T=0.0, C=1.0		Present				+	4	NM_001122740.1	c.729T>C	synonymous	0.22				Ligand-binding domain of nuclear hormone receptor,Oestrogen receptor,Zinc finger	rs4986934		0.018 (ref)	0.04	0.0082	0.0292	YES	Sertoli cell proliferation,T-tubule,androgen metabolic process,antral ovarian follicle growth,beta-catenin binding,cellular response to estrogen stimulus,chromatin binding,chromatin remodeling complex,cytoplasm,enzyme binding,epithelial cell development,epithelial cell proliferation involved in mammary gland duct elongation,estrogen receptor activity,estrogen response element binding,gene expression,hormone binding,intracellular estrogen receptor signaling pathway,mammary gland alveolus development,mammary gland branching involved in pregnancy,membrane,metal ion binding,mitochondrial part,neuron projection,neuroprotection,nitric-oxide synthase regulator activity,nucleoplasm,nucleus,osteoblast development,perikaryon,perinuclear region of cytoplasm,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of fibroblast proliferation,positive regulation of retinoic acid receptor signaling pathway,positive regulation of survival gene product expression,positive regulation of transcription from RNA polymerase II promoter,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,protein binding,protein complex binding,receptor activity,regulation of apoptotic process,regulation of branching involved in prostate gland morphogenesis,regulation of transcription, DNA-dependent,response to estradiol stimulus,response to estrogen stimulus,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,signal transduction,steroid binding,steroid hormone mediated signaling pathway,steroid hormone receptor activity,terminal button,transcription factor binding,transcription, DNA-dependent,type 1 metabotropic glutamate receptor binding,uterus development,vagina development,zinc ion binding	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-4-(2-PYRROLIDIN-1-YLETHOXY)PHENYLCHROMAN-6-OL,(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-9-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(9ALPHA,13BETA,17BETA)-2-(1Z)-BUT-1-EN-1-YLESTRA-1,3,5(10)-TRIENE-3,17-DIOL,(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL,1-4-(Octahydro-Pyrido1,2-aPyrazin-2-Yl)-Phenyl-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,2-AMINO-1-METHYL-6-PHENYLIMIDAZO4,5-BPYRIDINE,2-Phenyl-1-4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,4-(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(2-amino-1-methyl-1H-imidazo4,5-bpyridin-6-yl)phenol,4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL,4-1-allyl-7-(trifluoromethyl)-1H-indazol-3-ylbenzene-1,3-diol,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YLACETONITRILE,Allylestrenol,Chlorotrianisene,Clomifene,Compound 18,Compound 19,Compound 4-D,Conjugated Estrogens,DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO2.2.1HEPT-5-ENE-2,3-DICARBOXYLATE,Danazol,Desogestrel,Dienestrol,Diethylstilbestrol,Estradiol,Estramustine,Estriol,Estrone,Estropipate,Ethinyl Estradiol,Ethynodiol Diacetate,Etonogestrel,Fluoxymesterone,Fulvestrant,Genistein,Levonorgestrel,Medroxyprogesterone,Melatonin,Mestranol,N-(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,Naloxone,Norgestimate,Progesterone,Quinestrol,RALOXIFENE CORE,Raloxifene,Tamoxifen,Toremifene,Trilostane,dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo2.2.1hepta-2,5-diene-2,3-dicarboxylate		0.00001	30450.9	T=0, C=1997		T=0/0, C=859/1138	1	
chr6:152265522	C/C	G	SNV		ESR1	exonic	1								100.00	p.(=)		1651	G=0.0, C=1.0		Present				+	5	NM_001122740.1	c.975G>C	synonymous	-0.42				Ligand-binding domain of nuclear hormone receptor,Oestrogen receptor,Zinc finger	rs1801132		0.262 (ref)	0.2257	0.1074	0.1856	YES	Sertoli cell proliferation,T-tubule,androgen metabolic process,antral ovarian follicle growth,beta-catenin binding,cellular response to estrogen stimulus,chromatin binding,chromatin remodeling complex,cytoplasm,enzyme binding,epithelial cell development,epithelial cell proliferation involved in mammary gland duct elongation,estrogen receptor activity,estrogen response element binding,gene expression,hormone binding,intracellular estrogen receptor signaling pathway,mammary gland alveolus development,mammary gland branching involved in pregnancy,membrane,metal ion binding,mitochondrial part,neuron projection,neuroprotection,nitric-oxide synthase regulator activity,nucleoplasm,nucleus,osteoblast development,perikaryon,perinuclear region of cytoplasm,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of fibroblast proliferation,positive regulation of retinoic acid receptor signaling pathway,positive regulation of survival gene product expression,positive regulation of transcription from RNA polymerase II promoter,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,protein binding,protein complex binding,receptor activity,regulation of apoptotic process,regulation of branching involved in prostate gland morphogenesis,regulation of transcription, DNA-dependent,response to estradiol stimulus,response to estrogen stimulus,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,signal transduction,steroid binding,steroid hormone mediated signaling pathway,steroid hormone receptor activity,terminal button,transcription factor binding,transcription, DNA-dependent,type 1 metabotropic glutamate receptor binding,uterus development,vagina development,zinc ion binding	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-4-(2-PYRROLIDIN-1-YLETHOXY)PHENYLCHROMAN-6-OL,(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-9-OL,(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTACCHROMEN-8-OL,(9ALPHA,13BETA,17BETA)-2-(1Z)-BUT-1-EN-1-YLESTRA-1,3,5(10)-TRIENE-3,17-DIOL,(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL,1-4-(Octahydro-Pyrido1,2-aPyrazin-2-Yl)-Phenyl-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,2-AMINO-1-METHYL-6-PHENYLIMIDAZO4,5-BPYRIDINE,2-Phenyl-1-4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,4-(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO3.3.1NON-7-EN-2-YLPHENOL,4-(2-amino-1-methyl-1H-imidazo4,5-bpyridin-6-yl)phenol,4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL,4-1-allyl-7-(trifluoromethyl)-1H-indazol-3-ylbenzene-1,3-diol,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YLACETONITRILE,Allylestrenol,Chlorotrianisene,Clomifene,Compound 18,Compound 19,Compound 4-D,Conjugated Estrogens,DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO2.2.1HEPT-5-ENE-2,3-DICARBOXYLATE,Danazol,Desogestrel,Dienestrol,Diethylstilbestrol,Estradiol,Estramustine,Estriol,Estrone,Estropipate,Ethinyl Estradiol,Ethynodiol Diacetate,Etonogestrel,Fluoxymesterone,Fulvestrant,Genistein,Levonorgestrel,Medroxyprogesterone,Melatonin,Mestranol,N-(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,Naloxone,Norgestimate,Progesterone,Quinestrol,RALOXIFENE CORE,Raloxifene,Tamoxifen,Toremifene,Trilostane,dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo2.2.1hepta-2,5-diene-2,3-dicarboxylate		0.00001	24681.1	G=0, C=1651		G=0/0, C=849/802	1	
chr7:6013049	C/G	C	SNV		PMS2	exonic	1								45.18	p.Gly857Ala		228	C=0.5482, G=0.4518		Present				-	15	NM_000535.5	c.2570G>C	missense	0.33	0.19	60.0	0.0	DNA mismatch repair protein,Histidine kinase-	rs1802683		0.173 (ref)				YES	ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments	Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester	non-pathogenic,probable-non-pathogenic	0.00001	907.745	C=125, G=103		C=64/61, G=67/36	3	
chr7:6026775	C/C	T	SNV		PMS2	exonic	1								100.00	p.Lys541Glu		1986	T=0.0, C=1.0		Present				-	11	NM_000535.5	c.1621A>G	missense	0.74	1.0	56.0	0.0	DNA mismatch repair protein,Histidine kinase-	rs2228006		0.121 (ref)	0.1543	0.0815	0.1296	YES	ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments	Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester		0.00001	29996.9	T=0, C=1986		T=0/0, C=965/1021	4	
chr7:6026988	G/A	G	SNV		PMS2	exonic	1								41.30	p.Pro470Ser		2000	G=0.587, A=0.413		Present				-	11	NM_000535.5	c.1408C>T	missense	0.39	0.51	74.0	0.002	DNA mismatch repair protein,Histidine kinase-	rs1805321		0.394 (ref)	0.4209	0.2819	0.3738	YES	ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments	Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester	non-pathogenic	0.00001	6897.75	G=1174, A=826		G=584/590, A=411/415	2	
chr7:6036980	C/C	G	SNV		PMS2	exonic	1								100.00	p.(=)		1987	G=0.0, C=1.0		Present				-	7	NM_000535.5	c.780C>G	synonymous	-5.63				DNA mismatch repair protein,Histidine kinase-	rs1805319		0.157 (ref)	0.1852	0.1586	0.1762	YES	ATP binding,ATP catabolic process,ATPase activity,DNA binding,MutLalpha complex,MutSalpha complex binding,endonuclease activity,hydrolase activity,mismatch repair,mismatched DNA binding,nucleus,protein binding,reciprocal meiotic recombination,response to drug,single base insertion or deletion binding,single-stranded DNA binding,somatic hypermutation of immunoglobulin genes,somatic recombination of immunoglobulin gene segments	Adenosine-5'-Diphosphate,Phosphothiophosphoric Acid-Adenylate Ester	non-pathogenic	0.00001	30072.3	G=0, C=1987		G=0/0, C=998/989	2	
chr7:55220357		G	GENE_EXPRESSION		EGFR								EGFR.E6E7				3815				Present			2.0603e-09																						0.0					
chr7:55266417	C/C	T	SNV		EGFR	exonic	1								100.00	p.(=)		1995	T=0.0, C=1.0		Present				+	23	NM_005228.3	c.2709T>C	synonymous	-1.92				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain	rs1140475		0.095 (ref)	0.1267	0.0801	0.1109	YES	AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity	Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474		0.00001	30372.8	T=0, C=1995		T=0/0, C=1109/886	1	
chr7:55269475		G	GENE_EXPRESSION		EGFR								EGFR.E26E27				29				Present			1.5661e-11																						0.0					
chr7:92355033	T/A	T	SNV		CDK6	exonic	1								41.35	p.(=)		890	T=0.5865, A=0.4135		Present				-	4	NM_001145306.1	c.444A>T	synonymous	-0.44				Protein kinase domain,Protein tyrosine kinase	rs34257565		0.011 (ref)	0.0123	0.0025	0.009		ATP binding,G1 phase of mitotic cell cycle,G1/S transition of mitotic cell cycle,astrocyte development,cell cycle,cell cycle arrest,cell dedifferentiation,cell division,cyclin binding,cyclin-dependent protein kinase activity,cyclin-dependent protein kinase holoenzyme complex,cytoplasm,cytosol,dentate gyrus development,generation of neurons,gliogenesis,hemopoiesis,lateral ventricle development,mitotic cell cycle,negative regulation of cell cycle,negative regulation of cell differentiation,negative regulation of cell proliferation,negative regulation of cellular senescence,negative regulation of epithelial cell proliferation,negative regulation of myeloid cell differentiation,negative regulation of osteoblast differentiation,nucleotide binding,nucleus,positive regulation of cell-matrix adhesion,positive regulation of fibroblast proliferation,protein binding,protein phosphorylation,regulation of cell motility,regulation of erythrocyte differentiation,regulation of gene expression,response to virus,ruffle,type B pancreatic cell development	(2S)-2-({6-(3-AMINO-5-CHLOROPHENYL)AMINO-9-ISOPROPYL-9H-PURIN-2-YL}AMINO)-3-METHYLBUTAN-1-OL,3,7,3',4'-TETRAHYDROXYFLAVONE,Flavopiridol		0.00001	3054.48	T=522, A=368		T=239/283, A=176/192	1	
chr7:116364303		G	GENE_EXPRESSION		MET								MET-MET.E2E3.AltT				119				Present			6.4265e-11																						0.0					
chr7:116395569		C	GENE_EXPRESSION		MET								MET.E7E8				66624				Present			3.5980e-08																						0.0					
chr7:116411708		G	GENE_EXPRESSION		MET								MET.M13M14M15.WT				235				Present			1.2691e-10																						0.0					
chr7:116415165		G	GENE_EXPRESSION		MET								MET.E15E16				51276				Present			2.7691e-08																						0.0					
chr7:116419011		T	GENE_EXPRESSION		MET								MET-MET.M17M20.1				24				Present			1.2961e-11																						0.0					
chr7:116422151		T	GENE_EXPRESSION		MET								MET-MET.M18M20.1				855				Present			4.6174e-10																						0.0					
chr7:116422151		T	GENE_EXPRESSION		MET								MET.M18M19M20.WT				112				Present			6.0485e-11																						0.0					
chr7:116435768	T/T	C	SNV		MET	exonic	1								100.00	p.(=)		1982	C=0.0, T=1.0		Present				+	20	NM_001127500.1	c.3912C>T	synonymous	-3.37				IPT/TIG domain,Plexin repeat,Protein kinase domain,Protein tyrosine kinase,Sema domain	rs41736		0.372 (ref)	0.4243	0.1041	0.3235	YES	ATP binding,axon guidance,basal plasma membrane,cell proliferation,cell surface receptor linked signaling pathway,hepatocyte growth factor receptor signaling pathway,hepatocyte growth factor-activated receptor activity,integral to membrane,integral to plasma membrane,multicellular organismal development,nucleotide binding,plasma membrane,protein binding,protein tyrosine kinase activity,receptor activity,signal transduction	1-(2-NITROPHENYL)SULFONYL-1H-PYRROLO3,2-BPYRIDINE-6-CARBOXAMIDE,1-(4-fluorophenyl)-N-3-fluoro-4-(1H-pyrrolo2,3-bpyridin-4-yloxy)phenyl-2-oxo-1,2-dihydropyridine-3-carboxamide,2-(4-fluorophenyl)-N-{3-fluoro-4-(1H-pyrrolo2,3-bpyridin-4-yloxy)phenylcarbamoyl}acetamide,3-(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine,3-3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-ylphenol,6-{6-(1-methyl-1H-pyrazol-4-yl)1,2,4triazolo4,3-bpyridazin-3-ylsulfanyl}quinoline,K-252a,N-(3-chlorophenyl)-N-methyl-2-oxo-3-(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl-2H-indole-5-sulfonamide,N-({4-(2-aminopyridin-4-yl)oxy-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide		0.00001	29878.7	C=0, T=1982		C=0/0, T=1105/877	1	
chr7:116436022	A/A	G	SNV		MET	exonic	1								100.00	p.(=)		1817	G=0.0, A=1.0		Present				+	21	NM_001127500.1	c.4071G>A	synonymous	-3.55				IPT/TIG domain,Plexin repeat,Protein kinase domain,Protein tyrosine kinase,Sema domain	rs2023748		0.373 (ref)	0.4268	0.1029	0.3225	YES	ATP binding,axon guidance,basal plasma membrane,cell proliferation,cell surface receptor linked signaling pathway,hepatocyte growth factor receptor signaling pathway,hepatocyte growth factor-activated receptor activity,integral to membrane,integral to plasma membrane,multicellular organismal development,nucleotide binding,plasma membrane,protein binding,protein tyrosine kinase activity,receptor activity,signal transduction	1-(2-NITROPHENYL)SULFONYL-1H-PYRROLO3,2-BPYRIDINE-6-CARBOXAMIDE,1-(4-fluorophenyl)-N-3-fluoro-4-(1H-pyrrolo2,3-bpyridin-4-yloxy)phenyl-2-oxo-1,2-dihydropyridine-3-carboxamide,2-(4-fluorophenyl)-N-{3-fluoro-4-(1H-pyrrolo2,3-bpyridin-4-yloxy)phenylcarbamoyl}acetamide,3-(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine,3-3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-ylphenol,6-{6-(1-methyl-1H-pyrazol-4-yl)1,2,4triazolo4,3-bpyridazin-3-ylsulfanyl}quinoline,K-252a,N-(3-chlorophenyl)-N-methyl-2-oxo-3-(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl-2H-indole-5-sulfonamide,N-({4-(2-aminopyridin-4-yl)oxy-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide		0.00001	27633.9	G=0, A=1817		G=0/0, A=1056/761	1	
chr7:140439646		T	GENE_EXPRESSION		BRAF								BRAF.E16E17				22277				Present			1.2030e-08																						0.0					
chr7:140453136	ACTG/TCTG	ACTG	SNV		BRAF	exonic	1	Hotspot	Gain-of-function			HS	COSM26504;COSM6137;COSM18443;COSM476;COSM1583011;COSM474;COSM249889;COSM473;COSM1127;COSM1735763		ACTGTAGCTAGACCAAAATCTG=0.00, CCTG=0.00, GCTG=0.00, TCTG=57.24, CGTG=0.00, CTTG=0.00, TGTG=0.00, TTTG=0.00, CTCG=0.00, TTTA=0.00	p.Val600Glu		573	ACTG=0.4276, ACTGTAGCTAGACCAAAATCTG=0.0, CCTG=0.0, GCTG=0.0, TCTG=0.5724, CGTG=0.0, CTTG=0.0, TGTG=0.0, TTTG=0.0, CTCG=0.0, TTTA=0.0		Present				-	15	NM_004333.4	c.1799T>A	missense	2.17,2.69,2.17,2.69	0.0	121.0	0.971	C1-like domain,Phorbol esters/diacylglycerol binding domain (C1 domain),Protein kinase domain,Protein tyrosine kinase,Raf-like Ras-binding domain	rs113488022,rs121913227,rs121913374,rs121913375,rs121913377,rs121913378							ATP binding,MAP kinase kinase kinase activity,activation of MAPKK activity,anti-apoptosis,cytoplasm,cytosol,metal ion binding,mitogen-activated protein kinase kinase binding,negative regulation of apoptotic process,negative regulation of neuron apoptosis,nerve growth factor receptor signaling pathway,nucleotide binding,nucleus,organ morphogenesis,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of peptidyl-serine phosphorylation,protein binding,protein heterodimerization activity,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,receptor signaling protein activity,response to cAMP,response to peptide hormone stimulus,small GTPase mediated signal transduction,soluble fraction,synaptic transmission,synaptosome	(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime,N-{2,4-difluoro-3-(5-pyridin-3-yl-1H-pyrrolo2,3-bpyridin-3-yl)carbonylphenyl}ethanesulfonamide,N-{3-(5-chloro-1H-pyrrolo2,3-bpyridin-3-yl)carbonyl-2,4-difluorophenyl}propane-1-sulfonamide,Sorafenib	other,pathogenic	0.00001	3102.35	ACTG=245, ACTGTAGCTAGACCAAAATCTG=0, CCTG=0, GCTG=0, TCTG=328, CGTG=0, CTTG=0, TGTG=0, TTTG=0, CTCG=0, TTTA=0		ACTG=121/124, ACTGTAGCTAGACCAAAATCTG=0/0, CCTG=0/0, GCTG=0/0, TCTG=167/161, CGTG=0/0, CTTG=0/0, TGTG=0/0, TTTG=0/0, CTCG=0/0, TTTA=0/0	1,1,1,1,1,1,1,1,1,1	
chr7:140487347		C	GENE_EXPRESSION		BRAF								BRAF-BRAF.B3B9				427				Present			2.3060e-10																						0.0					
chr7:140501300		C	GENE_EXPRESSION		BRAF								BRAF.E5E6				4836				Present			2.6116e-09																						0.0					
chr8:90958422	T/C	T	SNV		NBN	exonic	1								54.17	p.(=)		240	T=0.4583, C=0.5417		Present				-	13	NM_002485.4	c.2016A>G	synonymous	-1.06				BRCA1 C Terminus (BRCT) domain,DNA damage repair protein Nbs1,FHA domain	rs1061302		0.328 (ref)	0.3132	0.2276	0.2842	YES	ATP-dependent DNA helicase activity,DNA damage checkpoint,DNA damage response, signal transduction by p53 class mediator,DNA duplex unwinding,DNA repair,G2/M transition checkpoint,Mre11 complex,apoptotic process,blastocyst growth,cell cycle,cell cycle arrest,chromosome,damaged DNA binding,double-strand break repair,double-strand break repair via homologous recombination,in utero embryonic development,intracellular,isotype switching,meiosis,mitotic cell cycle G1/S transition checkpoint,mitotic cell cycle G2/M transition DNA damage checkpoint,negative regulation of neuron differentiation,neuromuscular process controlling balance,nuclear chromosome, telomeric region,nuclear inclusion body,nucleolus,nucleoplasm,nucleus,positive regulation of cell proliferation,positive regulation of kinase activity,positive regulation of protein autophosphorylation,protein N-terminus binding,protein binding,regulation of DNA-dependent DNA replication initiation,regulation of fibroblast proliferation,replication fork,response to drug,telomere maintenance,transcription factor binding			0.00001	1296.39	T=110, C=130		T=45/65, C=62/68	1	
chr8:90967711	A/G	A	SNV		NBN	exonic	1								52.43	p.(=)		864	A=0.4757, G=0.5243		Present				-	10	NM_002485.4	c.1197T>C	synonymous	-0.48				BRCA1 C Terminus (BRCT) domain,DNA damage repair protein Nbs1,FHA domain	rs709816		0.424 (ref)	0.3559	0.2473	0.4903	YES	ATP-dependent DNA helicase activity,DNA damage checkpoint,DNA damage response, signal transduction by p53 class mediator,DNA duplex unwinding,DNA repair,G2/M transition checkpoint,Mre11 complex,apoptotic process,blastocyst growth,cell cycle,cell cycle arrest,chromosome,damaged DNA binding,double-strand break repair,double-strand break repair via homologous recombination,in utero embryonic development,intracellular,isotype switching,meiosis,mitotic cell cycle G1/S transition checkpoint,mitotic cell cycle G2/M transition DNA damage checkpoint,negative regulation of neuron differentiation,neuromuscular process controlling balance,nuclear chromosome, telomeric region,nuclear inclusion body,nucleolus,nucleoplasm,nucleus,positive regulation of cell proliferation,positive regulation of kinase activity,positive regulation of protein autophosphorylation,protein N-terminus binding,protein binding,regulation of DNA-dependent DNA replication initiation,regulation of fibroblast proliferation,replication fork,response to drug,telomere maintenance,transcription factor binding			0.00001	4367.93	A=411, G=453		A=246/165, G=299/154	1	
chr8:90990479	C/G	C	SNV		NBN	exonic	1								43.83	p.Glu185Gln		324	C=0.5617, G=0.4383		Present				-	5	NM_002485.4	c.553G>C	missense	0.09	1.0	29.0	0.0	BRCA1 C Terminus (BRCT) domain,DNA damage repair protein Nbs1,FHA domain	rs1805794		0.333 (ref)	0.3136	0.2338	0.2866	YES	ATP-dependent DNA helicase activity,DNA damage checkpoint,DNA damage response, signal transduction by p53 class mediator,DNA duplex unwinding,DNA repair,G2/M transition checkpoint,Mre11 complex,apoptotic process,blastocyst growth,cell cycle,cell cycle arrest,chromosome,damaged DNA binding,double-strand break repair,double-strand break repair via homologous recombination,in utero embryonic development,intracellular,isotype switching,meiosis,mitotic cell cycle G1/S transition checkpoint,mitotic cell cycle G2/M transition DNA damage checkpoint,negative regulation of neuron differentiation,neuromuscular process controlling balance,nuclear chromosome, telomeric region,nuclear inclusion body,nucleolus,nucleoplasm,nucleus,positive regulation of cell proliferation,positive regulation of kinase activity,positive regulation of protein autophosphorylation,protein N-terminus binding,protein binding,regulation of DNA-dependent DNA replication initiation,regulation of fibroblast proliferation,replication fork,response to drug,telomere maintenance,transcription factor binding			0.00001	1211.57	C=182, G=142		C=74/108, G=76/66	1	
chr8:90995019	C/T	C	SNV		NBN	exonic	1								46.20	p.(=)		1998	C=0.538, T=0.462		Present				-	2	NM_002485.4	c.102G>A	synonymous	-0.39				BRCA1 C Terminus (BRCT) domain,DNA damage repair protein Nbs1,FHA domain	rs1063045		0.35 (ref)	0.3147	0.3103	0.3132	YES	ATP-dependent DNA helicase activity,DNA damage checkpoint,DNA damage response, signal transduction by p53 class mediator,DNA duplex unwinding,DNA repair,G2/M transition checkpoint,Mre11 complex,apoptotic process,blastocyst growth,cell cycle,cell cycle arrest,chromosome,damaged DNA binding,double-strand break repair,double-strand break repair via homologous recombination,in utero embryonic development,intracellular,isotype switching,meiosis,mitotic cell cycle G1/S transition checkpoint,mitotic cell cycle G2/M transition DNA damage checkpoint,negative regulation of neuron differentiation,neuromuscular process controlling balance,nuclear chromosome, telomeric region,nuclear inclusion body,nucleolus,nucleoplasm,nucleus,positive regulation of cell proliferation,positive regulation of kinase activity,positive regulation of protein autophosphorylation,protein N-terminus binding,protein binding,regulation of DNA-dependent DNA replication initiation,regulation of fibroblast proliferation,replication fork,response to drug,telomere maintenance,transcription factor binding			0.00001	8265.44	C=1075, T=923		C=575/500, T=475/448	1	
chr9:80412471	G/A	G	SNV		GNAQ	exonic	1								65.60	p.(=)		1340	G=0.344, A=0.656		Present				-	4	NM_002072.4	c.570C>T	synonymous	0.81				G-protein alpha subunit								G-protein beta/gamma-subunit complex binding,G-protein coupled receptor binding,G-protein coupled receptor signaling pathway,GTP binding,GTP catabolic process,GTPase activator activity,GTPase activity,activation of adenylate cyclase activity by G-protein signaling pathway,activation of phospholipase C activity,activation of phospholipase C activity by dopamine receptor signaling pathway,behavior,blood coagulation,cytoplasm,developmental pigmentation,embryonic digit morphogenesis,extrinsic to internal side of plasma membrane,forebrain neuron development,glutamate signaling pathway,guanyl nucleotide binding,guanyl-nucleotide exchange factor activity,heart development,heterotrimeric G-protein complex,membrane fraction,metal ion binding,negative regulation of protein kinase activity,neuron remodeling,nucleotide binding,phospholipase C activity,plasma membrane,platelet activation,positive regulation of GTPase activity,post-embryonic development,protein ADP-ribosylation,protein binding,protein stabilization,regulation of action potential,regulation of catenin import into nucleus,regulation of melanocyte differentiation,signal transducer activity,skeletal system development			0.00001	9707.45	G=461, A=879		G=219/242, A=436/443	1	
chr9:98209594	G/A	G	SNV		PTCH1	exonic	1								14.62	p.Pro1315Leu		1779	G=0.8539, A=0.1461		Present				-	23	NM_000264.3	c.3944C>T	missense	2.51	0.0	98.0	0.906	Patched family	rs357564		0.382 (ref)	0.3298	0.2389	0.2993	YES	Golgi apparatus,brain development,branching involved in ureteric bud morphogenesis,caveola,cell differentiation involved in kidney development,cell proliferation involved in metanephros development,cellular response to cholesterol,cholesterol binding,cyclin binding,dorsal/ventral neural tube patterning,dorsal/ventral pattern formation,embryonic limb morphogenesis,epidermis development,glucose homeostasis,heart morphogenesis,hedgehog family protein binding,heparin binding,hindlimb morphogenesis,integral to plasma membrane,intracellular membrane-bounded organelle,keratinocyte proliferation,limb morphogenesis,mammary gland development,mammary gland duct morphogenesis,mammary gland epithelial cell differentiation,midbody,negative regulation of epithelial cell proliferation,negative regulation of multicellular organism growth,negative regulation of osteoblast differentiation,negative regulation of sequence-specific DNA binding transcription factor activity,negative regulation of smoothened signaling pathway,negative regulation of transcription from RNA polymerase II promoter,neural plate axis specification,neural tube closure,neural tube formation,neural tube patterning,organ morphogenesis,patched binding,pattern specification process,perinuclear region of cytoplasm,pharyngeal system development,plasma membrane,positive regulation of cholesterol efflux,protein binding,protein processing,protein targeting to plasma membrane,receptor activity,regulation of growth,regulation of mitotic cell cycle,regulation of protein localization,regulation of smoothened signaling pathway,renal system development,response to chlorate,signal transduction,smoothened binding,smoothened signaling pathway,somite development			0.00001	970.741	G=1519, A=260		G=701/818, A=116/144	6	
chr9:135782221	C/C	T	SNV		TSC1	exonic	1								100.00	p.(=)		625	T=0.0, C=1.0		Present				-	14	NM_000368.4	c.1335A>G	synonymous	0.43				Hamartin protein	rs7862221		0.14 (ref)	0.1463	0.219	0.1709	YES	GTPase activating protein binding,GTPase regulator activity,TSC1-TSC2 complex,actin filament,activation of Rho GTPase activity,cardiac muscle cell differentiation,cell cortex,cell cycle arrest,cell projection organization,cell-matrix adhesion,cerebral cortex development,chaperone binding,cytoplasm,cytosol,embryo development,growth cone,hippocampus development,insulin receptor signaling pathway,kidney development,lamellipodium,membrane,membrane fraction,microsome,myelination,negative regulation of TOR signaling cascade,negative regulation of cell proliferation,negative regulation of cell size,negative regulation of translation,nervous system development,neural tube closure,positive regulation of focal adhesion assembly,potassium ion transport,protein N-terminus binding,protein binding,protein complex,protein heterooligomerization,protein stabilization,rRNA export from nucleus,regulation of actin cytoskeleton organization,regulation of cell-matrix adhesion,regulation of phosphoprotein phosphatase activity,regulation of protein kinase activity,regulation of stress fiber assembly,regulation of translation,response to insulin stimulus,synapse organization		untested	0.00001	9448.26	T=0, C=625		T=0/0, C=303/322	2	
chr9:135786904	G/G	A	SNV		TSC1	exonic	1								100.00	p.Met322Thr		1995	A=0.0, G=1.0		Present				-	10	NM_000368.4	c.965T>C	missense	0.82	0.22	81.0	0.0	Hamartin protein	rs1073123		0.136 (ref)	0.1378	0.2195	0.1655	YES	GTPase activating protein binding,GTPase regulator activity,TSC1-TSC2 complex,actin filament,activation of Rho GTPase activity,cardiac muscle cell differentiation,cell cortex,cell cycle arrest,cell projection organization,cell-matrix adhesion,cerebral cortex development,chaperone binding,cytoplasm,cytosol,embryo development,growth cone,hippocampus development,insulin receptor signaling pathway,kidney development,lamellipodium,membrane,membrane fraction,microsome,myelination,negative regulation of TOR signaling cascade,negative regulation of cell proliferation,negative regulation of cell size,negative regulation of translation,nervous system development,neural tube closure,positive regulation of focal adhesion assembly,potassium ion transport,protein N-terminus binding,protein binding,protein complex,protein heterooligomerization,protein stabilization,rRNA export from nucleus,regulation of actin cytoskeleton organization,regulation of cell-matrix adhesion,regulation of phosphoprotein phosphatase activity,regulation of protein kinase activity,regulation of stress fiber assembly,regulation of translation,response to insulin stimulus,synapse organization		non-pathogenic	0.00001	30353.4	A=0, G=1995		A=0/0, G=1041/954	1	
chr9:139391636	G/A	G	SNV		NOTCH1	exonic	1								12.61	p.(=)		1752	G=0.8739, A=0.1261		Present				-	34	NM_017617.3	c.6555C>T	synonymous	-0.09				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein	rs2229974		0.305 (ref)	0.4467	0.3639	0.4187	YES	Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration			0.00001	708.468	G=1531, A=221		G=927/604, A=144/77	1	
chr9:139413121	T/C	T	SNV		MIR4673,NOTCH1	exonic, downstream	1								3.80	p.Ser341Gly		1976	T=0.962, C=0.038		Present				-	6	NM_017617.3, NR_039820.1	c.1021A>G	missense	1.92	0.51	56.0	0.091	Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,Laminin EGF-like (Domains III and V),NOTCH protein								Golgi apparatus,Golgi lumen,MAML1-RBP-Jkappa- ICN1 complex,Notch receptor processing,Notch signaling pathway,acrosomal vesicle,anagen,aortic valve morphogenesis,axonogenesis,branching morphogenesis of a tube,calcium ion binding,cell differentiation in spinal cord,cell fate specification,chromatin DNA binding,compartment pattern specification,core promoter binding,cytoplasm,cytosol,determination of left/right symmetry,embryo development,embryonic hindlimb morphogenesis,endoderm development,endoplasmic reticulum lumen,extracellular region,forebrain development,foregut morphogenesis,gene expression,hair follicle morphogenesis,heart development,immune response,in utero embryonic development,integral to membrane,liver development,lung development,negative regulation of BMP signaling pathway,negative regulation of apoptotic process,negative regulation of calcium ion-dependent exocytosis,negative regulation of cell death,negative regulation of cell-substrate adhesion,negative regulation of glial cell proliferation,negative regulation of myoblast differentiation,negative regulation of oligodendrocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,negative regulation of pro-B cell differentiation,negative regulation of stem cell differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,neural tube development,neuron fate commitment,neuronal stem cell maintenance,nucleoplasm,nucleus,organ regeneration,plasma membrane,positive regulation of BMP signaling pathway,positive regulation of JAK-STAT cascade,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of cell proliferation,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of keratinocyte differentiation,positive regulation of neuroblast proliferation,positive regulation of transcription of Notch receptor target,positive regulation of transcription, DNA-dependent,prostate gland epithelium morphogenesis,protein binding,receptor activity,regulation of cardioblast proliferation,regulation of developmental process,regulation of epithelial cell proliferation involved in prostate gland development,regulation of neurogenesis,regulation of somitogenesis,regulation of transcription, DNA-dependent,response to corticosteroid stimulus,response to lipopolysaccharide,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,sequence-specific DNA binding,sequence-specific DNA binding transcription factor activity,somatic stem cell division,spermatogenesis,sprouting angiogenesis,tissue regeneration			0.01749	17.5711	T=1901, C=75		T=879/1022, C=30/45	1	
chr10:43613843	T/T	G	SNV		RET	exonic	1								100.00	p.(=)		531	G=0.0, T=1.0		Present				+	13	NM_020975.4	c.2307G>T	synonymous	1.34				Cadherin domain,Protein kinase domain,Protein tyrosine kinase	rs1800861		0.277 (ref)	0.2347	0.1246	0.1974	YES	ATP binding,MAPKKK cascade,calcium ion binding,cellular response to retinoic acid,embryonic epithelial tube formation,endosome membrane,enteric nervous system development,homophilic cell adhesion,induction of apoptosis,integral to membrane,integral to plasma membrane,membrane,membrane protein proteolysis,nervous system development,neural crest cell migration,neuron maturation,nucleotide binding,positive regulation of cell adhesion mediated by integrin,positive regulation of cell migration,positive regulation of metanephric glomerulus development,positive regulation of neuron projection development,positive regulation of transcription, DNA-dependent,posterior midgut development,protein binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell adhesion,response to pain,signal transduction,transmembrane receptor protein tyrosine kinase activity,ureteric bud development	1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,4-BROMO-2-FLUORO-N-(4E)-6-METHOXY-7-(1-METHYLPIPERIDIN-4-YL)METHOXYQUINAZOLIN-4(1H)-YLIDENEANILINE,Imatinib	untested	0.00001	7762.07	G=0, T=531		G=0/0, T=261/270	1	
chr10:123298158	T/C	T	SNV		FGFR2	exonic	1								49.64	p.(=)		699	T=0.5036, C=0.4964		Present				-	6	NM_000141.4	c.696A>G	synonymous	0.96				Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs1047100		0.176 (ref)	0.2236	0.2522	0.2333	YES	ATP binding,Golgi apparatus,angiogenesis,apoptotic process,axonogenesis,bone development,bone mineralization,bone morphogenesis,branch elongation involved in salivary gland morphogenesis,branching involved in embryonic placenta morphogenesis,branching involved in prostate gland morphogenesis,branching involved in salivary gland morphogenesis,branching morphogenesis of a nerve,bud elongation involved in lung branching,cell cortex,cell fate commitment,cell surface,cell-cell signaling,cytoplasm,cytoplasmic membrane-bounded vesicle,digestive tract development,embryonic digestive tract morphogenesis,embryonic organ development,embryonic organ morphogenesis,embryonic pattern specification,epidermis morphogenesis,epithelial cell differentiation,epithelial cell proliferation involved in salivary gland morphogenesis,excitatory synapse,extracellular matrix,extracellular region,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,fibroblast growth factor-activated receptor activity,gland morphogenesis,hair follicle morphogenesis,heparin binding,in utero embryonic development,inner ear morphogenesis,insulin receptor signaling pathway,integral to membrane,integral to plasma membrane,lacrimal gland development,lateral sprouting from an epithelium,limb bud formation,lung alveolus development,lung development,lung lobe morphogenesis,lung-associated mesenchyme development,mammary gland bud formation,membrane,membranous septum morphogenesis,mesenchymal cell differentiation,mesenchymal cell differentiation involved in lung development,mesenchymal cell proliferation involved in lung development,midbrain development,morphogenesis of embryonic epithelium,multicellular organism growth,negative regulation of transcription from RNA polymerase II promoter,nucleotide binding,nucleus,odontogenesis,orbitofrontal cortex development,organ growth,organ morphogenesis,otic vesicle formation,outflow tract septum morphogenesis,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of Wnt receptor signaling pathway,positive regulation of canonical Wnt receptor signaling pathway,positive regulation of cardiac muscle cell proliferation,positive regulation of cell cycle,positive regulation of cell division,positive regulation of cell proliferation,positive regulation of epithelial cell proliferation,positive regulation of epithelial cell proliferation involved in lung morphogenesis,positive regulation of mesenchymal cell proliferation,positive regulation of phospholipase activity,positive regulation of transcription from RNA polymerase II promoter,post-embryonic development,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,prostate gland morphogenesis,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,pyramidal neuron development,receptor activity,regulation of ERK1 and ERK2 cascade,regulation of branching involved in prostate gland morphogenesis,regulation of cell fate commitment,regulation of fibroblast growth factor receptor signaling pathway,regulation of morphogenesis of a branching structure,regulation of multicellular organism growth,regulation of osteoblast differentiation,regulation of osteoblast proliferation,regulation of smooth muscle cell differentiation,regulation of smoothened signaling pathway,reproductive structure development,skeletal system morphogenesis,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,ureteric bud development,ventricular cardiac muscle tissue morphogenesis,ventricular zone neuroblast division	4-4-(1-Amino-1-Methylethyl)Phenyl-5-Chloro-N-4-(2-Morpholin-4-Ylethyl)PhenylPyrimidin-2-Amine,Palifermin,SU4984,Thalidomide		0.00001	3227.2	T=352, C=347		T=191/161, C=184/163	1	
chr11:108175462	G/A	G	SNV		ATM	exonic	1	Hotspot	Loss-of-function						35.34	p.Asp1853Asn		1995	G=0.6466, A=0.3534		Present				+	37	NM_000051.3	c.5557G>A	missense	2.75	0.07	23.0	0.044	FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase	rs1801516		0.079 (ref)	0.1402	0.0284	0.1023	YES	1-phosphatidylinositol-3-kinase activity,ATP binding,DNA binding,DNA damage induced protein phosphorylation,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent protein kinase activity,G2/M transition DNA damage checkpoint,brain development,cell cycle arrest,cell cycle checkpoint,cell death,cellular response to gamma radiation,chromosome, telomeric region,cytoplasm,cytoplasmic membrane-bounded vesicle,double-strand break repair,double-strand break repair via homologous recombination,female gamete generation,heart development,histone mRNA catabolic process,histone serine kinase activity,lipoprotein catabolic process,mitotic cell cycle spindle assembly checkpoint,negative regulation of B cell proliferation,negative regulation of apoptotic process,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,positive regulation of apoptotic process,positive regulation of neuron apoptosis,pre-B cell allelic exclusion,protein N-terminus binding,protein autophosphorylation,protein binding,protein complex binding,protein dimerization activity,protein serine/threonine kinase activity,reciprocal meiotic recombination,regulation of cell cycle,replicative senescence,response to DNA damage stimulus,response to hypoxia,response to ionizing radiation,signal transduction,somitogenesis,spindle			0.00001	5292.79	G=1290, A=705		G=661/629, A=408/297	1	
chr11:108183167	G/G	A	SNV		ATM	exonic	1								100.00	p.Asn1983Ser		1168	A=0.0, G=1.0		Present				+	40	NM_000051.3	c.5948A>G	missense	-0.19	1.0	46.0	0.0	FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase	rs659243		0.0 (ref)					1-phosphatidylinositol-3-kinase activity,ATP binding,DNA binding,DNA damage induced protein phosphorylation,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction resulting in induction of apoptosis,DNA repair,DNA-dependent protein kinase activity,G2/M transition DNA damage checkpoint,brain development,cell cycle arrest,cell cycle checkpoint,cell death,cellular response to gamma radiation,chromosome, telomeric region,cytoplasm,cytoplasmic membrane-bounded vesicle,double-strand break repair,double-strand break repair via homologous recombination,female gamete generation,heart development,histone mRNA catabolic process,histone serine kinase activity,lipoprotein catabolic process,mitotic cell cycle spindle assembly checkpoint,negative regulation of B cell proliferation,negative regulation of apoptotic process,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,positive regulation of DNA damage response, signal transduction by p53 class mediator,positive regulation of apoptotic process,positive regulation of neuron apoptosis,pre-B cell allelic exclusion,protein N-terminus binding,protein autophosphorylation,protein binding,protein complex binding,protein dimerization activity,protein serine/threonine kinase activity,reciprocal meiotic recombination,regulation of cell cycle,replicative senescence,response to DNA damage stimulus,response to hypoxia,response to ionizing radiation,signal transduction,somitogenesis,spindle			0.00001	17694.3	A=0, G=1168		A=0/0, G=694/474	2	
chr11:125525195	G/G	A	SNV		CHEK1	exonic	1								100.00	p.Ile471Val		1996	A=0.0, G=1.0		Present				+	13	NM_001274.5	c.1411A>G	missense	0.45	1.0	29.0	0.0	Protein kinase domain,Protein tyrosine kinase	rs506504		0.017 (ref)	0.0363	0.0064	0.0262	YES	ATP binding,DNA damage checkpoint,DNA damage induced protein phosphorylation,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,G2/M transition of mitotic cell cycle,cell cycle,cell cycle checkpoint,cellular response to caffeine,cellular response to mechanical stimulus,cellular response to organic substance,centrosome,chromatin,chromatin-mediated maintenance of transcription,chromosome, telomeric region,condensed nuclear chromosome,cytoplasm,cytoskeleton,histone H3-T11 phosphorylation,histone kinase activity (H3-T11 specific),negative regulation of mitosis,nucleoplasm,nucleotide binding,nucleus,peptidyl-threonine phosphorylation,protein binding,protein serine/threonine kinase activity,regulation of S phase,regulation of double-strand break repair via homologous recombination,regulation of histone H3-K9 acetylation,regulation of mitotic centrosome separation,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,replication fork,replicative senescence,response to DNA damage stimulus	(2R)-1-(5,6-DIPHENYL-7H-PYRROLO2,3-DPYRIMIDIN-4-YL)AMINOPROPAN-2-OL,(2R)-3-{(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO2,3-DPYRIMIDIN-4-YLIDENEAMINO}PROPANE-1,2-DIOL,(2S)-1-AMINO-3-(5-NITROQUINOLIN-8-YL)AMINOPROPAN-2-OL,(3-ENDO)-8-METHYL-8-AZABICYCLO3.2.1OCT-3-YL 1H-PYRROLO2,3-BPYRIDINE-3-CARBOXYLATE,(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE,(5,6-DIPHENYL-FURO2,3-DPYRIMIDIN-4-YLAMINO)-ACETIC,(5-{3-5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL,1-(2S)-4-(5-BROMO-1H-PYRAZOLO3,4-BPYRIDIN-4-YL)MORPHOLIN-2-YLMETHANAMINE,1-(2S)-4-(5-phenyl-1H-pyrazolo3,4-bpyridin-4-yl)morpholin-2-ylmethanamine,1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-2-(DIMETHYLAMINO)-1-METHYLETHOXYPYRAZIN-2-YL}UREA,18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE,2,2'-{9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYLBIS(OXY)}DIACETIC ACID,2-(5,6-DIPHENYLFURO2,3-DPYRIMIDIN-4-YL)AMINOETHANOL,2-(cyclohexylamino)benzoic acid,2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol,2-5,6-BIS-(4-METHOXY-PHENYL)-FURO2,3-DPYRIMIDIN-4-YLAMINO-ETHANOL,3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE,3-(5-{4-(AMINOMETHYL)PIPERIDIN-1-YLMETHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE,3-(5-{4-(AMINOMETHYL)PIPERIDIN-1-YLMETHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,3-AMINO-3-BENZYL-4.3.0BICYCLO-1,6-DIAZANONAN-2-ONE,4-(3S)-1-AZABICYCLO2.2.2OCT-3-YLAMINO-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE,4-(6-{(4-METHYLCYCLOHEXYL)AMINOMETHYL}-1,4-DIHYDROINDENO1,2-CPYRAZOL-3-YL)BENZOIC ACID,4-3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL-2-METHOXYPHENOL,4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl(phenyl)methanone,5,6,7,8-TETRAHYDRO1BENZOTHIENO2,3-DPYRIMIDIN-4(3H)-ONE,5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO4,3-CQUINOLIN-4-ONE,6-MORPHOLIN-4-YL-9H-PURINE,N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-1,3THIAZOLO5,4-CAZEPIN-2-YL)ACETAMIDE,N-(5,6-DIPHENYLFURO2,3-DPYRIMIDIN-4-YL)GLYCINE,N-{5-4-(4-METHYLPIPERAZIN-1-YL)PHENYL-1H-PYRROLO2,3-BPYRIDIN-3-YL}NICOTINAMIDE,REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO1,2,3-FG:3',2',1'-KLPYRROLO3,4-I1,6BENZODIAZOCINE-1,3(2H)-DIONE		0.00001	30390.0	A=0, G=1996		A=0/0, G=902/1094	1	
chr12:25368462	T/T	C	SNV		KRAS	exonic	1								100.00	p.(=)		389	C=0.0, T=1.0		Present				-	5	NM_033360.3	c.483G>A	synonymous	1.06				Miro-like protein,Ras family	rs4362222		0.0 (ref)	0.0	0.0043	0.0015		GDP binding,GMP binding,GTP binding,GTPase activity,LRR domain binding,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,activation of MAPKK activity,axon guidance,blood coagulation,cytokine-mediated signaling pathway,epidermal growth factor receptor signaling pathway,insulin receptor signaling pathway,leukocyte migration,membrane raft,mitochondrion,nerve growth factor receptor signaling pathway,nucleotide binding,plasma membrane,positive regulation of MAP kinase activity,positive regulation of NF-kappaB transcription factor activity,positive regulation of nitric-oxide synthase activity,protein binding,response to glucocorticoid stimulus,response to mineralocorticoid stimulus,signal transduction,small GTPase mediated signal transduction,social behavior	(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL-PHOSPHONIC ACID,FARNESYL,FARNESYL DIPHOSPHATE		0.00001	5862.58	C=0, T=389		C=0/0, T=214/175	3	
chr12:133208979	C/C	T	SNV		POLE	exonic	1								100.00	p.(=)		866	T=0.0, C=1.0		Present				-	45	NM_006231.3	c.6252A>G	synonymous	-2.14				DNA polymerase family B,Domain of unknown function (DUF1744)	rs5745022		0.307 (ref)	0.4157	0.2433	0.3573	YES	DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding	Cladribine		0.00001	13122.1	T=0, C=866		T=0/0, C=417/449	1	
chr12:133219831	C/C	T	SNV		POLE	exonic	1								100.00	p.(=)		1416	T=0.0, C=1.0		Present				-	35	NM_006231.3	c.4530A>G	synonymous	-2.11				DNA polymerase family B,Domain of unknown function (DUF1744)	rs5744944		0.416 (ref)	0.4306	0.2985	0.4776	YES	DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding	Cladribine		0.00001	21475.0	T=0, C=1416		T=0/0, C=472/944	1	
chr12:133220526	T/C	T	SNV		POLE	exonic	1								65.18	p.Asn1396Ser		1482	T=0.3482, C=0.6518		Present				-	33	NM_006231.3	c.4187A>G	missense	2.23	0.04	46.0	0.068	DNA polymerase family B,Domain of unknown function (DUF1744)	rs5744934		0.088 (ref)	0.1353	0.1364	0.1357	YES	DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding	Cladribine		0.00001	10613.7	T=516, C=966		T=247/269, C=489/477	2	
chr12:133236000	T/T	C	SNV		POLE	exonic	1								100.00	p.(=)		1997	C=0.0, T=1.0		Present				-	26	NM_006231.3	c.3156G>A	synonymous	-3.0				DNA polymerase family B,Domain of unknown function (DUF1744)	rs5744857		0.416 (ref)	0.4307	0.2985	0.4775	YES	DNA binding,DNA repair,DNA replication,DNA synthesis involved in DNA repair,DNA-dependent DNA replication initiation,DNA-directed DNA polymerase activity,G1/S transition of mitotic cell cycle,M/G1 transition of mitotic cell cycle,S phase of mitotic cell cycle,base-excision repair, gap-filling,chromatin binding,in utero embryonic development,metal ion binding,mitotic cell cycle,nucleobase-containing compound metabolic process,nucleoplasm,nucleotide binding,nucleotide-excision repair,nucleotide-excision repair, DNA gap filling,nucleotidyltransferase activity,nucleus,telomere maintenance,telomere maintenance via recombination,telomere maintenance via semi-conservative replication,transcription-coupled nucleotide-excision repair,transferase activity,zinc ion binding	Cladribine		0.00001	30384.3	C=0, T=1997		C=0/0, T=1056/941	1	
chr13:28636084	A/A	G	SNV		FLT3	exonic	1								100.00	p.(=)		1996	G=0.0, A=1.0		Present				-	3	NM_004119.2	c.288C>T	synonymous	0.04				Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs7338903		0.041 (ref)	0.0105	0.0978	0.0401	YES	ATP binding,cell surface,cellular response to cytokine stimulus,cytokine receptor activity,cytokine-mediated signaling pathway,endoplasmic reticulum,endoplasmic reticulum lumen,hemopoiesis,integral to plasma membrane,lymphocyte differentiation,membrane,myeloid progenitor cell differentiation,negative regulation of B cell differentiation,negative regulation of cell proliferation,nucleotide binding,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,positive regulation of MAP kinase activity,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of tyrosine phosphorylation of STAT protein,pro-B cell differentiation,pro-T cell differentiation,protein autophosphorylation,protein homodimerization activity,receptor activity,regulation of apoptotic process,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity	Sorafenib,Sunitinib		0.00001	30392.2	G=0, A=1996		G=0/0, A=1015/981	1	
chr13:32899321		G	GENE_EXPRESSION		BRCA2								BRCA2.E5E6				33327				Present			1.7998e-08																						0.0					
chr13:32900750		G	GENE_EXPRESSION		BRCA2								BRCA2-BRCA2.B7B10.V8				29				Present			1.5661e-11																						0.0					
chr13:32906729	A/C	A	SNV		BRCA2	exonic	1								63.66	p.Asn372His		1995	A=0.3634, C=0.6366		Present				+	10	NM_000059.3	c.1114A>C	missense	-0.15	0.15	68.0	0.023	BRCA2 repeat	rs144848		0.24 (ref)	0.2859	0.1289	0.2332	YES	BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis		non-pathogenic,other	0.00001	13828.5	A=725, C=1270		A=321/404, C=555/715	3	
chr13:32913055	G/G	A	SNV		BRCA2	exonic	1								100.00	p.(=)		1997	A=0.0, G=1.0		Present				+	11	NM_000059.3	c.4563A>G	synonymous	0.6				BRCA2 repeat	rs206075		0.026 (ref)	6.0E-4	0.0704	0.0242	YES	BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis			0.00001	30443.1	A=0, G=1997		A=0/0, G=1162/835	1	
chr13:32915005	C/C	G	SNV		BRCA2	exonic	1								100.00	p.(=)		1659	G=0.0, C=1.0		Present				+	11	NM_000059.3	c.6513G>C	synonymous	-1.1				BRCA2 repeat	rs206076		0.026 (ref)	6.0E-4	0.0713	0.0245	YES	BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis			0.00001	25205.8	G=0, C=1659		G=0/0, C=973/686	1	
chr13:32929387	C/C	T	SNV		BRCA2	exonic	1								100.00	p.Val2466Ala		970	T=0.0, C=1.0		Present				+	14	NM_000059.3	c.7397T>C	missense	1.27	0.58	64.0	0.0	BRCA2 repeat	rs169547		0.022 (ref)	6.0E-4	0.0647	0.0223	YES	BRCA2-MAGE-D1 complex,DNA binding,DNA recombination,DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,cell cycle,cell cycle cytokinesis,centrosome,centrosome duplication,cytoplasm,double-strand break repair,double-strand break repair via homologous recombination,gamma-tubulin binding,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,homologous chromosome orientation involved in meiotic metaphase I plate congression,mammary gland development,multicellular organism growth,negative regulation of mammary gland epithelial cell proliferation,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,positive regulation of transcription, DNA-dependent,protease binding,protein binding,protein complex,regulation of S phase of mitotic cell cycle,response to estradiol stimulus,response to nutrient,secretory granule,single-stranded DNA binding,spermatogenesis		untested	0.00001	14697.7	T=0, C=970		T=0/0, C=523/447	1	
chr13:32937670		G	GENE_EXPRESSION		BRCA2								BRCA2.E18E19				83				Present			4.4823e-11																						0.0					
chr13:48919335		G	GENE_EXPRESSION		RB1								RB1.E4E5				1752				Present			9.4615e-10																						0.0					
chr13:49050979		G	GENE_EXPRESSION		RB1								RB1.E26E27				3284				Present			1.7735e-09																						0.0					
chr15:88576185	C/C	G	SNV		NTRK3	exonic	1								100.00	p.(=)		864	G=0.0, C=1.0		Present				-	14	NM_001012338.2	c.1488C>G	synonymous	-2.01				Immunoglobulin I-set domain,Immunoglobulin domain,Leucine rich repeat N-terminal domain,Protein kinase domain,Protein tyrosine kinase	rs2229910		0.322 (ref)	0.3551	0.4048	0.3719	YES	ATP binding,Golgi membrane,cell differentiation,cellular response to retinoic acid,cochlea development,cytoplasm,integral to plasma membrane,mechanoreceptor differentiation,membrane fraction,modulation by virus of host transcription,multicellular organismal development,negative regulation of astrocyte differentiation,negative regulation of cell death,nervous system development,neuron fate specification,neuron migration,neurotrophin binding,nucleotide binding,plasma membrane,positive regulation of axon extension involved in regeneration,protein autophosphorylation,receptor activity,response to axon injury,response to corticosterone stimulus,response to ethanol,response to stress,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.00001	12905.9	G=0, C=864		G=0/0, C=387/477	2	
chr15:89838236	A/A	G	SNV		FANCI	exonic	1								100.00	p.(=)		1990	G=0.0, A=1.0		Present				+	24	NM_001113378.1	c.2547G>A	synonymous	0.3					rs7183618		0.027 (ref)	0.0535	0.0087	0.0399	YES	DNA repair,cell cycle,nucleoplasm,nucleus,plasma membrane,protein binding			0.00001	30113.1	G=0, A=1990		G=0/0, A=1050/940	2	
chr16:2113000	C/G	C	SNV		TSC2	exonic	1								71.50	p.Ile463Met		2000	C=0.285, G=0.715		Present				+	14	NM_000548.3	c.1389C>G	missense	1.16	0.22	10.0	0.997	Rap/ran-GAP,Tuberin								14-3-3 protein binding,GTPase activator activity,Golgi apparatus,TSC1-TSC2 complex,acute-phase response,caveola,cell cycle arrest,cell projection organization,cytoplasm,cytoskeletal part,cytosol,dendrite,endocytosis,establishment of protein localization,fibroblast growth factor receptor signaling pathway,growth cone,heart development,insulin receptor signaling pathway,insulin-like growth factor receptor signaling pathway,intracellular,membrane,membrane fraction,microsome,negative regulation of MAP kinase activity,negative regulation of TOR signaling cascade,negative regulation of Wnt receptor signaling pathway,negative regulation of cell proliferation,negative regulation of cell size,negative regulation of epithelial cell proliferation,negative regulation of phosphatidylinositol 3-kinase cascade,negative regulation of protein kinase B signaling cascade,negative regulation of protein kinase activity,nerve growth factor receptor signaling pathway,neural tube closure,neuronal cell body,nucleus,perinuclear region of cytoplasm,phosphatase binding,phosphatidylinositol-mediated signaling,positive chemotaxis,positive regulation of GTPase activity,protein binding,protein heterodimerization activity,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,protein import into nucleus,protein kinase B signaling cascade,protein localization,regulation of cell cycle,regulation of endocytosis,regulation of insulin receptor signaling pathway,regulation of small GTPase mediated signal transduction,response to hypoxia,signal transduction,vesicle-mediated transport			0.00001	16720.2	C=570, G=1430		C=293/277, G=739/691	1	
chr16:2138269	T/C	T	SNV		PKD1,TSC2	exonic, downstream	1								77.92	p.(=)		1997	T=0.2208, C=0.7792		Present				+, -	41	NM_000548.3, NM_001009944.2	c.5202T>C	synonymous	0.34				Rap/ran-GAP,Tuberin	rs137854091,rs1748		0.258	0.1781	0.3656	0.3325	YES	14-3-3 protein binding,GTPase activator activity,Golgi apparatus,JAK-STAT cascade,TSC1-TSC2 complex,acute-phase response,anatomical structure morphogenesis,basolateral plasma membrane,blood vessel development,branching morphogenesis of a tube,calcium ion transport,calcium-independent cell-matrix adhesion,cartilage condensation,cation channel activity,caveola,cell cycle arrest,cell projection organization,cell-matrix adhesion,cilium,cytoplasm,cytoskeletal part,cytosol,dendrite,detection of mechanical stimulus,endocytosis,establishment of protein localization,fibroblast growth factor receptor signaling pathway,growth cone,heart development,homophilic cell adhesion,in utero embryonic development,insulin receptor signaling pathway,insulin-like growth factor receptor signaling pathway,integral to plasma membrane,intracellular,membrane,membrane fraction,microsome,motile primary cilium,negative regulation of MAP kinase activity,negative regulation of TOR signaling cascade,negative regulation of Wnt receptor signaling pathway,negative regulation of cell proliferation,negative regulation of cell size,negative regulation of epithelial cell proliferation,negative regulation of phosphatidylinositol 3-kinase cascade,negative regulation of protein kinase B signaling cascade,negative regulation of protein kinase activity,nerve growth factor receptor signaling pathway,neural tube closure,neuronal cell body,neuropeptide signaling pathway,nucleus,perinuclear region of cytoplasm,phosphatase binding,phosphatidylinositol-mediated signaling,plasma membrane,polycystin complex,positive chemotaxis,positive regulation of GTPase activity,protein binding,protein domain specific binding,protein heterodimerization activity,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,protein import into nucleus,protein kinase B signaling cascade,protein kinase binding,protein localization,regulation of cell cycle,regulation of endocytosis,regulation of insulin receptor signaling pathway,regulation of small GTPase mediated signal transduction,response to hypoxia,signal transduction,sugar binding,vesicle-mediated transport		untested	0.00001	19225.2	T=441, C=1556		T=210/231, C=830/726	1	
chr16:2138584	G/C	G	SNV		PKD1,TSC2	exonic, downstream	1								70.72	p.(=)		1998	G=0.2928, C=0.7072		Present				+, -	42	NM_000548.3, NM_001009944.2	c.5397G>C	synonymous	-5.34				Rap/ran-GAP,Tuberin	rs1051771		0.047 (ref)	0.0987	0.0187	0.0716	YES	14-3-3 protein binding,GTPase activator activity,Golgi apparatus,JAK-STAT cascade,TSC1-TSC2 complex,acute-phase response,anatomical structure morphogenesis,basolateral plasma membrane,blood vessel development,branching morphogenesis of a tube,calcium ion transport,calcium-independent cell-matrix adhesion,cartilage condensation,cation channel activity,caveola,cell cycle arrest,cell projection organization,cell-matrix adhesion,cilium,cytoplasm,cytoskeletal part,cytosol,dendrite,detection of mechanical stimulus,endocytosis,establishment of protein localization,fibroblast growth factor receptor signaling pathway,growth cone,heart development,homophilic cell adhesion,in utero embryonic development,insulin receptor signaling pathway,insulin-like growth factor receptor signaling pathway,integral to plasma membrane,intracellular,membrane,membrane fraction,microsome,motile primary cilium,negative regulation of MAP kinase activity,negative regulation of TOR signaling cascade,negative regulation of Wnt receptor signaling pathway,negative regulation of cell proliferation,negative regulation of cell size,negative regulation of epithelial cell proliferation,negative regulation of phosphatidylinositol 3-kinase cascade,negative regulation of protein kinase B signaling cascade,negative regulation of protein kinase activity,nerve growth factor receptor signaling pathway,neural tube closure,neuronal cell body,neuropeptide signaling pathway,nucleus,perinuclear region of cytoplasm,phosphatase binding,phosphatidylinositol-mediated signaling,plasma membrane,polycystin complex,positive chemotaxis,positive regulation of GTPase activity,protein binding,protein domain specific binding,protein heterodimerization activity,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,protein import into nucleus,protein kinase B signaling cascade,protein kinase binding,protein localization,regulation of cell cycle,regulation of endocytosis,regulation of insulin receptor signaling pathway,regulation of small GTPase mediated signal transduction,response to hypoxia,signal transduction,sugar binding,vesicle-mediated transport		untested	0.00001	16417.3	G=585, C=1413		G=280/305, C=661/752	2	
chr16:3639139	A/G	A	SNV		SLX4	exonic	1								69.28	p.(=)		1999	A=0.3072, G=0.6928		Present				-	12	NM_032444.2	c.4500T>C	synonymous	0.83				BTB/POZ domain	rs3810812		0.306 (ref)	0.4923	0.1406	0.3734	YES	3'-flap endonuclease activity,5'-flap endonuclease activity,DNA double-strand break processing involved in repair via single-strand annealing,DNA recombination,DNA repair,ERCC4-ERCC1 complex,Holliday junction resolvase complex,Slx1-Slx4 complex,crossover junction endodeoxyribonuclease activity,double-strand break repair via homologous recombination,enzyme activator activity,nuclear chromatin,nuclear chromosome, telomeric region,nucleotide-excision repair,nucleus,positive regulation of catalytic activity,protein binding			0.00001	15882.6	A=614, G=1385		A=274/340, G=569/816	1	
chr16:89849480	C/T	C	SNV		FANCA	exonic	1								49.30	p.Gly501Ser		2000	C=0.507, T=0.493		Present				-	16	NM_000135.2	c.1501G>A	missense	-1.69	1.0	56.0	0.0	Fanconi anaemia group A protein	rs2239359		0.393 (ref)	0.381	0.3196	0.4823	YES	DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,male gonad development,male meiosis,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation			0.00001	9180.61	C=1014, T=986		C=441/573, T=384/602	2	
chr16:89883007	A/T	A	SNV		FANCA	exonic	1								49.39	p.Val6Asp		1312	A=0.5061, T=0.4939		Present				-	1	NM_000135.2	c.17T>A	missense	-0.15	0.04	152.0	0.072	Fanconi anaemia group A protein	rs1800282		0.051 (ref)	0.0664	0.0143	0.05	YES	DNA repair,Fanconi anaemia nuclear complex,cytoplasm,female gonad development,male gonad development,male meiosis,nucleoplasm,nucleus,protein binding,protein complex assembly,regulation of cell proliferation			0.00001	6045.64	A=664, T=648		A=113/551, T=129/519	1	
chr17:7579472	G/C	G	SNV		TP53	exonic	1								96.25	p.Pro72Arg		2000	G=0.0375, C=0.9625		Present				-	4	NM_000546.5	c.215C>G	missense	1.36	0.6	103.0	0.083	P53 DNA-binding domain,P53 tetramerisation motif,P53 transactivation motif	rs1042522		0.398 (ref)	0.2548	0.4051	0.37	YES	ATP binding,B cell lineage commitment,DNA binding,DNA damage response, signal transduction by p53 class mediator,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA strand annealing activity,DNA strand renaturation,ER overload response,MDM2 binding,PML body,RNA polymerase II transcription factor binding,Ras protein signal transduction,T cell differentiation in thymus,T cell lineage commitment,T cell proliferation involved in immune response,activation of caspase activity by cytochrome c,apoptotic process,base-excision repair,blood coagulation,cell aging,cell cycle arrest,cell cycle checkpoint,cell differentiation,cell proliferation,cellular protein localization,cellular response to UV,cellular response to drug,cellular response to glucose starvation,cellular response to hypoxia,cellular response to ionizing radiation,central nervous system development,chaperone binding,chromatin,chromatin assembly complex,chromatin binding,chromosome organization,copper ion binding,cytoplasm,cytosol,damaged DNA binding,determination of adult lifespan,double-strand break repair,embryo development ending in birth or egg hatching,endoplasmic reticulum,enzyme binding,gastrulation,histone acetyltransferase binding,histone deacetylase regulator activity,identical protein binding,in utero embryonic development,induction of apoptosis by intracellular signals,insoluble fraction,interspecies interaction between organisms,metal ion binding,mitochondrion,mitotic cell cycle G1/S transition DNA damage checkpoint,multicellular organism growth,multicellular organismal development,negative regulation of DNA replication,negative regulation of apoptotic process,negative regulation of cell growth,negative regulation of cell proliferation,negative regulation of fibroblast proliferation,negative regulation of helicase activity,negative regulation of neuroblast proliferation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,negative regulation of transforming growth factor beta receptor signaling pathway,nuclear body,nuclear chromatin,nuclear matrix,nucleolus,nucleoplasm,nucleotide-excision repair,nucleus,oxidative stress-induced premature senescence,p53 binding,positive regulation of apoptotic process,positive regulation of cell aging,positive regulation of cell cycle arrest,positive regulation of histone deacetylation,positive regulation of neuron apoptosis,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of reactive oxygen species metabolic process,positive regulation of thymocyte apoptosis,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protease binding,protein N-terminus binding,protein binding,protein complex,protein complex assembly,protein heterodimerization activity,protein import into nucleus, translocation,protein kinase binding,protein localization,protein phosphatase 2A binding,protein tetramerization,rRNA transcription,regulation of apoptotic process,regulation of cell cycle,regulation of mitochondrial membrane permeability,regulation of transcription, DNA-dependent,release of cytochrome c from mitochondria,replication fork,replicative senescence,response to DNA damage stimulus,response to X-ray,response to antibiotic,response to gamma radiation,sequence-specific DNA binding transcription factor activity,signal transduction by p53 class mediator resulting in induction of apoptosis,somitogenesis,transcription factor TFIID complex,transcription factor binding,transcription regulatory region DNA binding,ubiquitin protein ligase binding,zinc ion binding	1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine	non-pathogenic	0.00001	28028.8	G=75, C=1925		G=9/66, C=657/1268	6	
chr17:29508775	A/A	G	SNV		NF1	exonic	1								100.00	p.(=)		811	G=0.0, A=1.0		Present				+	7	NM_001042492.2	c.702G>A	synonymous	-3.81				GTPase-activator protein for Ras-like GTPase	rs1801052		0.45 (ref)	0.2899	0.3098	0.4256	YES	MAPKKK cascade,Ras GTPase activator activity,Ras protein signal transduction,Schwann cell development,actin cytoskeleton organization,adrenal gland development,artery morphogenesis,axon,brain development,camera-type eye morphogenesis,cell communication,cerebral cortex development,cognition,collagen fibril organization,cytoplasm,dendrite,extracellular matrix organization,forebrain astrocyte development,forebrain morphogenesis,heart development,intracellular,intrinsic to internal side of plasma membrane,liver development,metanephros development,myelination in peripheral nervous system,negative regulation of MAP kinase activity,negative regulation of MAPKKK cascade,negative regulation of Rac protein signal transduction,negative regulation of Ras protein signal transduction,negative regulation of angiogenesis,negative regulation of astrocyte differentiation,negative regulation of cell migration,negative regulation of endothelial cell proliferation,negative regulation of fibroblast proliferation,negative regulation of neuroblast proliferation,negative regulation of neurotransmitter secretion,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase activity,negative regulation of transcription factor import into nucleus,neural tube development,nucleus,osteoblast differentiation,peripheral nervous system development,phosphatidylinositol 3-kinase cascade,pigmentation,positive regulation of Ras GTPase activity,positive regulation of adenylate cyclase activity,positive regulation of apoptotic process,positive regulation of endothelial cell proliferation,positive regulation of neuron apoptosis,protein binding,regulation of Ras GTPase activity,regulation of angiogenesis,regulation of blood vessel endothelial cell migration,regulation of bone resorption,regulation of cell-matrix adhesion,regulation of glial cell differentiation,regulation of long-term neuronal synaptic plasticity,regulation of small GTPase mediated signal transduction,regulation of synaptic transmission, GABAergic,response to hypoxia,signal transduction,skeletal muscle tissue development,smooth muscle tissue development,spinal cord development,sympathetic nervous system development,visual learning,wound healing			0.00001	12219.2	G=0, A=811		G=0/0, A=556/255	1	
chr17:33433487	C/T	C	SNV		RAD51D,RAD51L3-RFFL	exonic_nc, exonic, exonic, exonic, exonic_nc, exonic_nc	1								48.75	p.Arg53Gln, p.Arg185Gln, p.Arg165Gln		1996	C=0.5125, T=0.4875		Present				-	6	NR_037714.1, NM_133629.2, NM_001142571.1, NM_002878.3, NR_037712.1, NR_037711.1	c.158G>A, c.554G>A, c.494G>A	missense, missense, missense	-0.16		43.0, 43.0, 43.0			rs4796033		0.097 (ref)	0.1427	0.0368	0.1068	YES	ATP binding,DNA binding,DNA metabolic process,DNA recombination,DNA repair,DNA-dependent ATPase activity,nucleoside-triphosphatase activity,nucleotide binding,nucleus,reciprocal meiotic recombination			0.00001	8995.53	C=1023, T=973		C=473/550, T=442/531	2	
chr17:33445549	G/A	G	SNV		RAD51D,RAD51L3-RFFL	intronic_nc, intronic, intronic, exonic, intronic_nc, intronic_nc	1								47.77	p.(=)		1997	G=0.5223, A=0.4777		Present				-	3	NR_037714.1, NM_133629.2, NM_001142571.1, NM_002878.3, NR_037712.1, NR_037711.1	c.234C>T	synonymous	1.21					rs9901455		0.191 (ref)	0.082	0.308	0.1585	YES	ATP binding,DNA binding,DNA metabolic process,DNA recombination,DNA repair,DNA-dependent ATPase activity,nucleoside-triphosphatase activity,nucleotide binding,nucleus,reciprocal meiotic recombination			0.00001	8719.99	G=1043, A=954		G=472/571, A=438/516	2	
chr17:37873733		C	GENE_EXPRESSION		ERBB2								ERBB2.E19E20E21.WT				1676				Present			9.0511e-10																						0.0					
chr17:41199659		C	GENE_EXPRESSION		BRCA1								BRCA1-BRCA1.B20B23.V21es				22				Present			1.1881e-11																						0.0					
chr17:41215907		C	GENE_EXPRESSION		BRCA1								BRCA1-BRCA1.B15B18				8061				Present			4.3533e-09																						0.0					
chr17:41215907		C	GENE_EXPRESSION		BRCA1								BRCA1-BRCA1.B16B18				162				Present			8.7487e-11																						0.0					
chr17:41223094	T/C	T	SNV		BRCA1	exonic	1								51.45	p.Ser1634Gly		1998	T=0.4855, C=0.5145		Present				-	16	NM_007300.3	c.4900A>G	missense	0.13	0.03	56.0	0.58	BRCA1 C Terminus (BRCT) domain,Zinc finger	rs1799966		0.327	0.3266	0.2426	0.2982	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		non-pathogenic	0.00001	9817.41	T=970, C=1028		T=426/544, C=505/523	1	
chr17:41226462		T	GENE_EXPRESSION		BRCA1								BRCA1-BRCA1.B13B15.V14es				62				Present			3.3483e-11																						0.0					
chr17:41226462		T	GENE_EXPRESSION		BRCA1								BRCA1-BRCA1.B4B15.V5es				179				Present			9.6667e-11																						0.0					
chr17:41234470	A/G	A	SNV		BRCA1	exonic	1								52.55	p.(=)		1998	A=0.4745, G=0.5255		Present				-	12	NM_007300.3	c.4308T>C	synonymous	0.13				BRCA1 C Terminus (BRCT) domain,Zinc finger	rs1060915		0.304 (ref)	0.326	0.1888	0.2796	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		untested	0.00001	10173.7	A=948, G=1050		A=503/445, G=502/548	2	
chr17:41244000	T/C	T	SNV		BRCA1	exonic	1								52.48	p.Lys1183Arg		1999	T=0.4752, C=0.5248		Present				-	10	NM_007300.3	c.3548A>G	missense	-0.44	1.0	26.0	0.0	BRCA1 C Terminus (BRCT) domain,Zinc finger	rs16942,rs80357956		0.324 (ref)	0.3244	0.2383	0.2952	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		non-pathogenic	0.00001	10154.9	T=950, C=1049		T=540/410, C=543/506	3	
chr17:41244435	T/C	T	SNV		BRCA1	exonic	1								51.08	p.Glu1038Gly		1999	T=0.4892, C=0.5108		Present				-	10	NM_007300.3	c.3113A>G	missense	0.11	0.02	98.0	0.158	BRCA1 C Terminus (BRCT) domain,Zinc finger	rs16941,rs80357920		0.303 (ref)	0.3255	0.1884	0.279	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		non-pathogenic	0.00001	9721.73	T=978, C=1021		T=472/506, C=516/505	2	
chr17:41244936	G/A	G	SNV		BRCA1	exonic	1								49.47	p.Pro871Leu		1999	G=0.5053, A=0.4947		Present				-	10	NM_007300.3	c.2612C>T	missense	0.94	1.0	98.0	0.0	BRCA1 C Terminus (BRCT) domain,Zinc finger	rs799917,rs80357962		0.483	0.3359	0.2	0.4932	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		non-pathogenic	0.00001	9236.2	G=1010, A=989		G=511/499, A=497/492	2	
chr17:41245237	A/G	A	SNV		BRCA1	exonic	1								49.82	p.(=)		1999	A=0.5018, G=0.4982		Present				-	10	NM_007300.3	c.2311T>C	synonymous	-0.83				BRCA1 C Terminus (BRCT) domain,Zinc finger	rs16940		0.302 (ref)	0.3237	0.1877	0.2776	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		untested	0.00001	9339.52	A=1003, G=996		A=501/502, G=490/506	2	
chr17:41245466	G/A	G	SNV		BRCA1	exonic	1								47.05	p.(=)		2000	G=0.5295, A=0.4705		Present				-	10	NM_007300.3	c.2082C>T	synonymous	-0.08				BRCA1 C Terminus (BRCT) domain,Zinc finger	rs1799949		0.324 (ref)	0.3244	0.2396	0.2957	YES	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding		untested	0.00001	8521.54	G=1059, A=941		G=595/464, A=528/413	1	
chr17:41247862		C	GENE_EXPRESSION		BRCA1								BRCA1-BRCA1.B7B9.V8				193				Present			1.0423e-10																						0.0					
chr17:41247862		C	GENE_EXPRESSION		BRCA1								BRCA1.B7B8B9.WT				42				Present			2.2682e-11																						0.0					
chr17:41256152		T	GENE_EXPRESSION		BRCA1								BRCA1.E5E6				2302				Present			1.2432e-09																						0.0					
chr17:56435885	G/T	G	SNV		RNF43	exonic	1								46.86	p.Leu418Met		1991	G=0.5314, T=0.4686		Present				-	9	NM_017763.4	c.1252C>A	missense	2.18	0.0	15.0	0.948	Zinc finger	rs2526374		0.398 (ref)	0.3591	0.4024	0.3738	YES	endoplasmic reticulum,endoplasmic reticulum membrane,integral to membrane,ligase activity,membrane,metal ion binding,nuclear envelope,nucleus,protein binding,zinc ion binding			0.00001	8421.84	G=1058, T=933		G=519/539, T=478/455	1	
chr17:56435936	C/T	C	SNV		RNF43	exonic	1								49.95	p.Glu401Lys		2000	C=0.5005, T=0.4995		Present				-	9	NM_017763.4	c.1201G>A	missense	2.07	0.03	56.0	0.421	Zinc finger								endoplasmic reticulum,endoplasmic reticulum membrane,integral to membrane,ligase activity,membrane,metal ion binding,nuclear envelope,nucleus,protein binding,zinc ion binding			0.00001	9360.98	C=1001, T=999		C=599/402, T=553/446	1	
chr17:56436109	C/T	C	SNV		RNF43	exonic	1								50.95	p.Arg343His		1898	C=0.4905, T=0.5095		Present				-	9	NM_017763.4	c.1028G>A	missense	0.89	0.02	29.0	0.999	Zinc finger	rs34523089		0.076 (ref)	0.1585	0.0362	0.1171	YES	endoplasmic reticulum,endoplasmic reticulum membrane,integral to membrane,ligase activity,membrane,metal ion binding,nuclear envelope,nucleus,protein binding,zinc ion binding			0.00001	9191.94	C=931, T=967		C=545/386, T=596/371	1	
chr17:56438301	G/A	G	SNV		RNF43	exonic	1								49.00	p.Pro231Leu		2000	G=0.51, A=0.49		Present				-	7	NM_017763.4	c.692C>T	missense	0.94	0.07	98.0	0.76	Zinc finger	rs2680701		0.102 (ref)	0.2023	0.0481	0.1501	YES	endoplasmic reticulum,endoplasmic reticulum membrane,integral to membrane,ligase activity,membrane,metal ion binding,nuclear envelope,nucleus,protein binding,zinc ion binding			0.00001	9093.86	G=1020, A=980		G=451/569, A=462/518	2	
chr17:56492800	T/C	T	SNV		RNF43	exonic	1								52.40	p.Ile47Val		2000	T=0.476, C=0.524		Present				-	2	NM_017763.4	c.139A>G	missense	0.97	0.1	29.0	0.001	Zinc finger	rs3744093		0.392 (ref)	0.3851	0.2174	0.3283	YES	endoplasmic reticulum,endoplasmic reticulum membrane,integral to membrane,ligase activity,membrane,metal ion binding,nuclear envelope,nucleus,protein binding,zinc ion binding			0.00001	10133.1	T=952, C=1048		T=469/483, C=552/496	1	
chr19:11105608	T/C	T	SNV		SMARCA4	exonic	1								63.68	p.(=)		1999	T=0.3632, C=0.6368		Present				+	9	NM_001128849.1	c.1524T>C	synonymous	-1.57				BRK domain,Bromodomain,HSA,Helicase conserved C-terminal domain,SNF2 family N-terminal domain	rs7935		0.312 (ref)	0.3409	0.3037	0.3283	YES	ATP binding,DNA binding,DNA methylation on cytosine within a CG sequence,SWI/SNF complex,blastocyst growth,blastocyst hatching,cell morphogenesis,chromatin binding,chromatin remodeling,definitive erythrocyte differentiation,embryonic hindlimb morphogenesis,embryonic organ morphogenesis,epidermis morphogenesis,extracellular matrix organization,forebrain development,glial cell fate determination,heart development,heart trabecula formation,helicase activity,heterochromatin,hindbrain development,histone H3 acetylation,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,in utero embryonic development,keratinocyte differentiation,liver development,methylation-dependent chromatin silencing,nBAF complex,negative regulation of transcription from RNA polymerase II promoter,nervous system development,npBAF complex,nuclear euchromatin,nucleus,perichromatin fibrils,positive regulation of transcription from RNA polymerase II promoter,regulation of transcription, DNA-dependent,soluble fraction,transcription factor binding,vasculogenesis			0.00001	13851.4	T=726, C=1273		T=355/371, C=666/607	1	
chr19:15271771	A/A	G	SNV		NOTCH3	exonic	1								100.00	p.Ala2223Val		1994	G=0.0, A=1.0		Present				-	33	NM_000435.2	c.6668C>T	missense	0.08	0.18	64.0	0.001	Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1044009		0.368 (ref)	0.1987	0.397	0.2651	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	30337.8	G=0, A=1994		G=0/0, A=915/1079	1	
chr19:15278057	G/G	A	SNV		NOTCH3	splicesite_3	1								100.00			1997	A=0.0, G=1.0		Present				-	29	NM_000435.2			0.62				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1548555		0.133 (ref)	0.1034	0.0236	0.0763	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	30451.4	A=0, G=1997		A=0/0, G=917/1080	2	
chr19:15285052	C/C	T	SNV		NOTCH3	exonic	1								100.00	p.(=)		1997	T=0.0, C=1.0		Present				-	25	NM_000435.2	c.4563A>G	synonymous	-1.43				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1044006		0.133 (ref)	0.1002	0.0223	0.0739	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	30428.2	T=0, C=1997		T=0/0, C=885/1112	1	
chr19:15292437	C/C	T	SNV		NOTCH3	exonic	1								100.00	p.(=)		1352	T=0.0, C=1.0		Present				-	17	NM_000435.2	c.2742A>G	synonymous	-4.38				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1043997		0.233 (ref)	0.1299	0.3636	0.2095	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	20546.5	T=0, C=1352		T=0/0, C=708/644	1	
chr19:15295134	A/A	G	SNV		NOTCH3	exonic	1								100.00	p.(=)		1243	G=0.0, A=1.0		Present				-	16	NM_000435.2	c.2538C>T	synonymous	-0.59				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1043996		0.462 (ref)	0.2849	0.2762	0.4336	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	18664.2	G=0, A=1243		G=0/0, A=650/593	1	
chr19:15302844	C/C	T	SNV		NOTCH3	exonic	1								100.00	p.(=)		1999	T=0.0, C=1.0		Present				-	4	NM_000435.2	c.606A>G	synonymous	-2.59				Ankyrin repeat,Calcium-binding EGF domain,EGF-like domain,LNR domain,NOTCH protein	rs1043994		0.144 (ref)	0.1224	0.0878	0.1107	YES	Golgi lumen,Notch receptor processing,Notch signaling pathway,calcium ion binding,cytosol,endoplasmic reticulum lumen,extracellular region,forebrain development,gene expression,integral to membrane,multicellular organismal development,negative regulation of neuron differentiation,neuron fate commitment,nucleoplasm,nucleus,plasma membrane,protein binding,receptor activity,regulation of developmental process,regulation of transcription, DNA-dependent,tissue regeneration			0.00001	30450.1	T=0, C=1999		T=0/0, C=844/1155	1	
chr19:30314666	C/T	C	SNV		CCNE1	exonic	1								39.93	p.(=)		1440	C=0.6007, T=0.3993		Present				+	12	NM_001238.2	c.1215C>T	synonymous	-1.18				Cyclin	rs7257694		0.216 (ref)	0.3899	0.111	0.2954	YES	DNA-dependent DNA replication initiation,G1/S transition of mitotic cell cycle,Wnt receptor signaling pathway,androgen receptor binding,androgen receptor signaling pathway,antral ovarian follicle growth,cell division,cellular response to nutrient,centrosome,cyclin-dependent protein kinase holoenzyme complex,cyclin-dependent protein kinase regulator activity,cytoplasm,cytosol,kinase activity,liver development,mitotic cell cycle,nucleolus,nucleoplasm,nucleus,organ regeneration,positive regulation of cell differentiation,positive regulation of transcription, DNA-dependent,protein binding,protein kinase binding,protein phosphorylation,regulation of cyclin-dependent protein kinase activity,regulation of transcription involved in G1/S phase of mitotic cell cycle,response to corticosterone stimulus,response to cytokine stimulus,response to drug,response to estradiol stimulus,response to ethanol,response to methylmercury,response to organic nitrogen,response to progesterone stimulus,response to purine-containing compound,response to vitamin E,transcription coactivator activity			0.00001	4674.42	C=865, T=575		C=495/370, T=348/227	1	
chr20:36030939	C/C	G	SNV		SRC	exonic	1								100.00	p.(=)		1242	G=0.0, C=1.0		Present				+	12	NM_198291.2	c.1218G>C	synonymous	-2.02				Protein kinase domain,Protein tyrosine kinase,SH2 domain,SH3 domain,Variant SH3 domain	rs1885257		0.012 (ref)					ATP binding,Ras protein signal transduction,SH2 domain binding,SH3/SH2 adaptor activity,T cell costimulation,axon guidance,blood coagulation,bone resorption,branching involved in mammary gland duct morphogenesis,caveola,cell adhesion,cell cycle,cell junction assembly,cellular membrane organization,cytoplasm,cytoskeleton,cytosol,ephrin receptor binding,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,forebrain development,heme binding,integrin binding,interspecies interaction between organisms,intracellular protein kinase cascade,ion channel binding,kinase activity,leukocyte migration,mitochondrial inner membrane,mitochondrion,nerve growth factor receptor signaling pathway,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,oogenesis,peptidyl-tyrosine phosphorylation,phosphorylation,plasma membrane,platelet activation,positive regulation of integrin activation,protein binding,protein kinase activity,protein phosphorylation,protein tyrosine kinase activity,receptor binding,regulation of bone resorption,regulation of intracellular estrogen receptor signaling pathway,regulation of vascular permeability,response to interleukin-1,signal complex assembly,signal transduction,uterus development	(2E)-N-{4-(3-bromophenyl)aminoquinazolin-6-yl}-4-(dimethylamino)but-2-enamide,1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo3,4-dpyrimidin-4-amine,1-1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl-3-naphthalen-1-ylurea,1-1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl-3-phenylurea,1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo3,4-dpyrimidin-4-amine,1-cyclopentyl-3-(1H-pyrrolo2,3-bpyridin-5-yl)-1H-pyrazolo3,4-dpyrimidin-4-amine,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,3-4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO3,4-DPYRIMIDIN-3-YLPHENOL,4-(4-METHYL-1-PIPERAZINYL)METHYL-N-3-4-(3-PYRIDINYL)-2-PYRIMIDINYLAMINOPHENYL-BENZAMIDE,4-({4-(5-cyclopropyl-1H-pyrazol-3-yl)aminoquinazolin-2-yl}amino)phenylacetonitrile,Citric Acid,DPI59,Dasatinib,ISO24,Malonic acid,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,N6-Benzyl Adenosine-5'-Diphosphate,Oxalic Acid,PAS219,PASBN,Phenylphosphate,Phosphonotyrosine,Purvalanol A,RU78191,RU78262,RU78299,RU78300,RU78783,RU79072,RU79073,RU79256,RU81843,RU82129,RU82197,RU82209,RU83876,RU84687,RU85053,RU85493,RU90395		0.00001	18734.9	G=0, C=1242		G=0/0, C=582/660	2	
chrX:66766604		G	GENE_EXPRESSION		AR								AR.E1E2				165				Present			8.9107e-11																						0.0					
chrX:66942826		T	GENE_EXPRESSION		AR								AR.E7E8				19101				Present			1.0315e-08																						0.0					
